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Abstract 
Oxidative stress is a biological state that occurs due to imbalance between reactive 
oxygen species (ROS) and the antioxidant system leading to subcellular disturbance. 
The purpose of this thesis was to determine changes in protein abundance/distribution 
between nuclear and cytoplasmic cell compartments in the normal human IMR90 
fibroblasts subjected to mild oxidative stress. The experimental design was to exert tert-
butyl hydrogen peroxide upon the IMR90 cell lines to induce mild oxidative stress 
followed by fractionation of the cells into nucleus and cytoplasm. Cellular response was 
measured by the use of subcellular spatial razor approach based on quantitative shotgun 
LC-MS/MS-based proteomics with SILAC isotope labeling. It has been found that, in 
response to the treatment, proteins were redistributed between nucleus and cytoplasm 
including numerous proteins that were not previously known to associate with oxidative 
stress. We found 121 most significant proteins with known function at unexpected 
subcellular location. These proteins were known to contribute to different cellular 
processes such as, transcription, iron/haem metabolism, TCA cycle, glycolysis, 
autophagy, signal transduction and ATP synthesis, and are consistent with functional 
networks that are spatially distributed across the cell. Specific metabolic pathways of 
NRF2 and proline regulatory axis were found to play an important part on the cellular 
response to mild oxidative stress. Iron metabolism with iron/haem as a cofactor and 
mitochondrial proteins were prominent into the response as well. By initial comparison 
of the oxidative stress fibroblasts with Cdc7 depleted fibroblasts after induction of 
origin activation checkpoint, it was found that both responses affect proteins related to 
glycolysis, TCA cycle and proline regulatory axis. Evidence suggested nuclear 
import/export of proteins induced by the treatment. Subcellular spatial razor results for 
response of fibroblasts to oxidative stress clearly suggested that, to obtain 
comprehensive pictures of cellular function, measurements of global changes in total 
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protein abundance need to be combined with measurement of the dynamic subcellular 
spatial redistribution of proteins.     
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Chapter 1: Introduction 
 
Oxidative stress is a biological state that occurs due to imbalance between reactive 
oxygen species (ROS) and cell antioxidant components (Halliwell, 2007, Halliwell and 
Gutteridge, 2007). Alternatively, it can be defined as the damage caused by ROS to 
proteins, lipids and DNA leading to cellular pathology (Jenkins, 2000, Cross et al., 
1987). 
The term ROS was first used in 1945. Later on, more than 140,000 English language 
articles and more than 15,000 reviews were written about this subject. Most of the 
articles were predominately connecting ROS either with physiological states such as 
cell division cycle, immune defence system, signal transduction, apoptosis and 
antibacterial action or to pathological conditions such as aging, cancer, diabetes and 
cardiovascular diseases. ROS need to be under control by antioxidant defence systems 
(Alfadda and Sallam, 2012, Burhans and Heintz, 2009b).  
It is obvious that an excessive oxidative stress may harm the cells and cause 
macromolecular damaging, protein aggregation (Sohal, 2002) and protein dysfunction 
leading to cell death. However, the low level of stress is needed for balancing of protein 
expression (Vogel et al., 2011). Moreover, distribution of proteins over subcellular 
organelles is highly dynamic and affected by different conditions (Hansen et al., 2006, 
Henke et al., 2011, Jung et al., 2013, Mulvey et al., 2013, Qattan et al., 2012, Pinto et 
al., 2014). This thesis investigated the influence of mild oxidative stress, by the use of 
spatial razor subcellular quantitative proteomics approach, with an aim to determine 
changes in protein abundances and distribution between the nucleus and cytoplasm of 
human IMR90 fibroblasts. The results obtained were compared to the results previously 
obtained in Cdc7-depleted human IMR90 fibroblasts (Mulvey et al., 2013).  
In the following sections of the introduction, the literature relative to this work is 
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reviewed focussing in ROS, oxidative stress and their roles under both physiological 
and pathological conditions, while the second section is about the application of 
quantitative proteomics to study proteins spatial dynamic changes under oxidative 
stress. 
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1.1 General ROS Physiology 
 
ROS are active molecules that are produced mainly from the electron transport chain of 
the mitochondria (ETC) by the conversion of oxygen molecules into superoxide anion 
(O2−) by univalent reduction process. It can also be generated in other cellular locations 
such as phagocytes. ROS can be by-products by different enzymes such as NADPH 
oxidases (Nox) or nitric oxide synthase (eNOS) and related proteins (Droge, 2002, 
Babior et al., 2002, Chen et al., 2008, Gough and Cotter, 2011, Block and Gorin, 2012, 
Bedard and Krause, 2007). ROS molecules include hydrogen peroxide (H2O2), reactive 
nitrogen species (NO), superoxide anion (O2−) and hydroxyl radicals (OH.). All these 
molecules play important physiological roles in healthy cells (Cross et al., 1987, 
Fridovich, 1984, Orient et al., 2007, Pacher et al., 2007), such as regulation of redox 
signaling pathways (Figure 1-1), which includes mediating H2O2 oxidation to the 
protein’s cysteine residues (Rhee, 2006). At physiological pH, cysteine residues exist as 
thiolate anion (Cys-S-) that is more sensitive to oxidation compared to the protonated 
cysteine thiolate (Cys-SH) (Finkel, 2012). Redox signaling may be mediated by Cys-S- 
H2O2 oxidation to the sulfenic form (Cys-SOH) thus altering protein function. However, 
this reaction is mostly reversible in case of moderate oxidation and protein function may 
be retrieved back to Cys-S by reduction process in the presence of reductase enzymes 
thioredoxin (Trx) and glutaredoxin (Grx) (Winterbourn and Hampton, 2008, Schieber 
and Chandel, 2014). On the other hand, high exposure to H2O2 oxidation converts 
proteins thiolate anion into sulfonic (SO3H-) or sulfinic (SO2H-) anions which are 
irreversible forms leading to permanent protein damage.  
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Figure 1-1. ROS Biology. Intercellular superoxide (O2-) is produced either by 
mitochondrial aerobic respiration due to leaking of electrons or via the NADPH and 
NOX enzymes. In the presence of antioxidant superoxide dismutases (SODs) enzymes, 
superoxide is quickly converted into hydrogen peroxide (H2O2). H2O2 may in turn 
oxidize the cysteine residues of proteins, forming thiolate anion (Cys-S-), and thus 
initiating redox signaling. Alternatively, antioxidant proteins such as glutathione 
peroxidase (GPX), peroxiredoxins (PRX) and catalase (CAT) can convert H2O2 into 
water. If the levels of H2O2 dramatically increase, hydroxyl radicals (OH.) are generated 
from reaction with iron cations (Fe2+) that may permanently inactivate the cellular 
macromolecules. Figure adapted and modified according to figure in (Schieber and 
Chandel, 2014).   
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Therefore, in order to reduce the risk of intracellular build up of H2O2, cells produce 
protective antioxidant enzymes such as glutathione peroxidases (GPX), catalase (CAT) 
and peroxiredoxins (PRX), which act to convert H2O2 into water (Schieber and 
Chandel, 2014). For proteins that contain iron-sulfur clusters, enzymes like superoxide 
dismutase SOD1 (Cu/Zn SOD), located in the internal mitochondria membrane space 
and cytoplasm and SOD2 (Mn SOD), located in the mitochondrial matrix, prevent 
superoxide accumulation by converting O2- into H2O2 (Fridovich, 1997). Accumulation 
of superoxide is more connected to oxidative stress than redox signaling particularly 
with autophagy mechanism. Superoxide only affects some proteins, thus leading either 
to adaptation to oxidative stress, or starting a cellular death program (i.e. apoptosis) 
(Chen et al., 2009b, Murphy, 2012). Active hydroxyl radical (OH.) is one of the ROS 
molecules, that is generated by reaction of H2O2 with ferrous ions in the Fenton’s 
reaction. It randomly oxidizes lipids, DNA and proteins, thus causing chemical 
modifications and genomic instability (Dizdaroglu and Jaruga, 2012, Schieber and 
Chandel, 2014).  
Eukaryotic cells often need growth factors for cell proliferation, nutrient uptake, and 
survival (Cooper and Hausman, 2004, Thompson, 2011). These growth factors such as 
epidermal growth factor (EGF), and platelet-derived growth factor (PDGF) induce 
protein tyrosine kinases receptors (PTKs) and their tyrosine kinase activity to 
phosphorylate the receptor cytoplasmic tails at specific tyrosine residues (Lemmon and 
Schlessinger, 2010). The receptor activation leads to down regulation and stimulation of 
important signal transduction pathways such as RAS-MEK-ERK MAP kinase cascade 
and phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway. PI3K pathway and 
RTKs can be inhibited by, for example, tumour suppresser PTEN and tyrosine 
phosphatases (PTPs) leading to a weaken mitogenic signaling (Tonks, 2006). For that 
reason, it is very important for these phosphatases to be under control to assure 
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sustaining signal transduction pathways (Schieber and Chandel, 2014). Growth factor 
such as EGF quickly and transiently increases ROS formation from NADPH oxidases to 
stimulate PTKs which in turn leads H2O2 to inactivation of protein tyrosine phosphatase 
PTP type 1B by oxidation of its cysteine residues to sulfonic acid (Bae et al., 1997). 
PTP B1 generally dephosphorylates EGF receptor in tyrosine residues and inactivation 
of it by H2O2 leads to increasing the EGF receptor phosphorylation and its downstream 
signaling (Adachi et al., 1996). However, PTP B1 can be reactivated by thioredoxin 
(Lee et al., 1998). Moreover, antioxidant PRX has been found to govern and reduce 
H2O2 generation upon the EGF stimulation depending on the molecular localization 
(Woo et al., 2010). The compartmentalization of ROS production is crucial for 
differentiation of their origin, as ROS can be elevated due to redox signaling or 
oxidative damage. For example, in redox biology for the efficient signals, proteins that 
depend on H2O2 are likely to be presented near the H2O2 sources. The proteins that 
control the H2O2 production from NADH in the plasma membrane are as well 
compartmentalized accordingly. In addition, mitochondria are known to have the ability 
to move toward their target due to cellular state such as hypoxia (Al-Mehdi et al., 2012). 
Moreover, the accumulation of superoxide in cytosol has a different outcome than 
accumulation in the mitochondrial matrix due to the high abundance of iron-sulfur 
proteins in the mitochondrial matrix. These differences have been found between 
cytosolic SOD1 and mitochondrial SOD2. Knockdown of SOD2 in mice and neuronal 
cells showed to be far more severe pathogenic comparing to SOD1 knockdown 
(Schieber and Chandel, 2014, Fukui and Zhu, 2010).  Thus, the role of ROS and their 
subcellular location are generally very important for the regulation of different cellular 
functions.  
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1.1.1 Role of ROS in Cell Division and Cell Cycle Regulation   
 
ROS are important for the activation of checkpoints and thus the cell cycle regulation 
(Burhans and Heintz, 2009b). Cell division cycle is a vital process whose mechanism is 
tightly regulated and rigorously checked by checkpoints, which are placed in between 
the cell cycle phases to avoid any damage to cellular genomic materials (Hartwell and 
Weinert, 1989). The division cycle for most of the eukaryotic cells passes through four 
stages: cell growth, DNA copying, chromosome distribution and cell division. These 
stages encompass two main phases that regulate the division process of cells: interphase 
and mitotic phase. Interphase is the longest phase with approximately 95% of the 
duration and is divided into: G1 (Gap 1), S (synthesis) and G2 (Gap2) phases (Figure 1-
2A). Each phase plays an important role and is regulated by different groups of proteins. 
In addition, at the G1 phase, cells can abandon cellular division by entering the G0 
phase (quiescent) and stay metabolically highly active but away from proliferation. 
Mitosis (M phase) consists of four stages: prophase, metaphase, anaphase and 
telophase, followed by cytokinesis, which includes cytoplasm segregation to form the 
two daughter cells. Most of the critical events during the cell division occur in S phase 
with the DNA synthesis and replication and in M phase when the parental cell separates 
into two daughter cells. Movement of cells through the cycle phases is promoted by a 
family of proteins known as cyclin-dependent kinases (CDKs) and cyclins as their 
regulatory activators (Figure 1-2B) (Cooper and Hausman, 2004, Blow and Gillespie, 
2008, Garrett, 2001, Morgan, 2006, Williams and Stoeber, 2012). CDKs are usually 
regulated via phosphorylation but also can be negatively regulated by CDK inhibitors 
(CDKIs), which promote cell cycle withdrawal. CDKIs consist of two inhibitor 
families: Ink4 that includes p16Ink4A, p15Ink4B, p18Ink4C and p19InK4D, which inhibit 
CDK4 and CDK6 leading to G1 arrest. Cip/Kip family includes p21, p27 and p57 which 
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inhibit CDK2 and most of CDKs (Williams and Stoeber, 2012, Morgan, 1997, Orzaez 
et al., 2009, Sherr and Roberts, 1999).  
Elevation of cellular ROS level has been found to control the key cell cycle proteins 
(Havens et al., 2006). The CDKs inhibitor, p21 inhibits G1/S CDKs by many stressors 
such as oxidant agents (Gartel and Radhakrishnan, 2005).  
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Figure 1-2. The Cell Division Cycle.  A. Two main phases that control the cell cycle division 
process are Interphase and Mitosis. Interphase includes G1, S and G2. M phase includes 
prophase, metaphase, anaphase, telophase and cytokinesis  
(http://www.tutorvista.com/content/biology/biology-iii/cell-reproduction/cell-cycle.php Data 
accessed on 30-11-2014). B. The figure illustrates stages of the cell cycle with positions of 
regulatory cyclins/Cdcks and the main checkpoints. Figure originally adapted from (Orzaez et 
al., 2009).   
 
A. 
B. 
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In G1, ROS control mitogenic pathways that are important for activation of CDKs and 
phosphorylation of retinoblastoma protein (pRB) for S phase entry. Under oxidative 
stress, nuclear factor erythroid 2-related factor 2 protein (Nrf2) and forkhead box 
protein 3a (FoxO3a) control cell survival and lead to cell cycle arrest via specific factors 
such as CDKs inhibitor, p27 activation and stimulation of antioxidant enzymes. In S 
phase, ROS can induce S phase arrest via pRB dephosphorylation by phosphatase 2A 
(PP2A) protein, which negatively regulates signaling pathways initiated by protein 
kinases (Burhans and Heintz, 2009a). The stress transcriptional factors forkhead box 
Foxo proteins activate the p27CDK inhibitor, up regulate SOD1, and withdraw cells out 
of the cycle without apoptosis, as a response to the oxidative stress, thus leading to G1 
arrest (Fu and Tindall, 2008, Sedding, 2008, Kops et al., 2002b). This results in 
reduction of ROS levels and activation of AMPK pathway, tumour suppressor p53 and 
activation of cell cycle checkpoints.  
In fact, most of the cells stay out of the division cell cycle and remain at G0 phase, 
unless there are specific circumstances requiring them to enter the division cycle again 
(Jones et al., 2005). FoxO3a with Nrf2 are always functional in G0 phase in order to 
prevent the damage occurring from ROS accumulation, which might cause malignant 
transformation of cells (Kops et al., 2002a, Burhans and Heintz, 2009b, Osburn and 
Kensler, 2008, Kobayashi and Yamamoto, 2005).  
It is noteworthy that re-entry to the cycle is not regulated by cyclin/CDKs but by the 
redox dependent signaling pathways. Redox signaling triggers the core cell cycle genes 
and cyclins D even in the absence of growth factors and active PTKs (Latella et al., 
2001). Sarsour et al. proposed that O2- is more linked to proliferation while H2O2 is 
more linked to quiescence (Sarsour et al., 2008).  
 
 
	   31 
1.1.1.1 Oxidative Stress and Origin DNA Activation Checkpoint 
 
The purpose of checkpoints is to detect any abnormal changes arising during the 
division process such as DNA damage (Garrett, 2001). If unfavourable conditions are 
detected, checkpoints halt the cycle by inducing cell cycle arrest until the problem is 
resolved. Checkpoints are located at specific sites of the cell cycle and each one has 
their well-defined function (Garrett, 2001, Hartwell and Weinert, 1989, Bartek et al., 
2004, Musacchio and Salmon, 2007). In addition to such well-defined checkpoints a 
novel checkpoint monitoring DNA replication origin activation in G1/S phase has been 
recently revealed, which was the subject of our interest. Montagnoli et al. have found 
that S phase entry can be prevented in normal fibroblasts by inactivation of 
minichromosome maintenance complex Mcm helicase using small interference RNA 
(RNAi) against cell division cycle 7 (Cdc7) protein, which is an important kinase for 
phosphorylation of MCM complex and initiation of DNA replication. Cells are thus 
arrested in G1 phase by activating the novel checkpoint called the origin activation 
checkpoint (Montagnoli et al., 2004).   
Briefly, cell division cycle 7 protein (Cdc7) has an important role during origins 
activation and breaking of DNA double strand but not in formation of replication forks 
(Montagnoli et al., 2004). It is estimated that 30,000 replication origins are scattered 
along the human DNA (Mechali, 2001, Biamonti et al., 2003). Initiation of DNA 
replication occurs between G1 and S phases and consist of two steps: licensing and 
firing (Yekezare et al., 2013). In early G1 the origin replication complex (ORC) binds to 
DNA and recruits Cdc6 and Cdt1, which in turn loads mini-chromosome maintenance 
replicative helicase Mcm2-7 onto the DNA. Together, they form pre-replicative 
complex (pre-RC). In late G1 phase, the origins are “fired” by phosphorylation of pre-
RC through specific Cdk/Cyclins and Cdc7/ASK (Bell and Dutta, 2002, Blow and 
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Gillespie, 2008, Sclafani and Holzen, 2007). Cdc7 phosphorylates subunits of Mcm2, 4, 
and 6 leading to conformational changes and activation of Mcm helicase. This 
activation allows recruiting of other accessories such as Cdc45 and GINS complex, 
which is important for the establishment of DNA replication fork. In the S phase, DNA 
synthesis is started by forming bidirectional replication fork and loading their 
accessories (Figure 1-3) (Swords et al., 2010, Williams and Stoeber, 2012).  
In contrast to normal cells, it has been shown that types of malignant cells lack this 
novel checkpoint and proceed to an abortive S phase which lead to cell death 
(Montagnoli et al., 2004, Rodriguez-Acebes et al., 2010, Kulkarni et al., 2009). In order 
to clarify this possibly novel mechanism Gillespie and Blow 2008 have argued that 
perturbation of replication initiation could delay progression of the cycle from G1 into S 
(Blow and Gillespie, 2008). Motagnoli et al.  (Montagnoli et al., 2004) have found that 
it is possible to prevent S phase entry in fibroblasts by tendering Cdc7 RNAi and thus 
arresting cells in G1 phase. 
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Figure 1-3. DNA Replication Initiation Pathway and the Function of Cdc7.  After mitosis 
and in early G1, DNA replication pathway is initiated by origin replication complex (ORC) that 
recognizes and binds to replication origins. ORC recruits other proteins Cdc6 and Cdt1which in 
tern load the Mcm2-7 complex to the origins to form a pre-RC (pre- replicative complex). For 
origin activation, in late G1, both Cdc7/ASK and Cdk2/Cyclin become active and phosphorylate 
Mcm2-7 complex to trigger a conformational change that is required for unwinding of DNA 
which in turn leads to loading of other accessory factors such as Cdc45 and the GINS complex 
and generating a replication fork. Figure modified according to figure in (Sawa and Masai, 
2009).  
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This finding allowed Stoeber and his colleagues to investigate and reveal the molecular 
architecture of this enigmatic checkpoint in normal human diploid fibroblasts (Figure 1-
4) (Tudzarova et al., 2010). They revealed that depletion of Cdc7 triggers a fully 
reversible arrest of the cell cycle via activation of groups of proto-oncogenes and 
tumour suppressors as follows: FoxO3a boosts the activation of p14/ARF followed by 
loss of Hdm2. This destabilizes Mdm2 while stabilizing p53, activating p21and up-
regulating the CDK inhibitor p15INK4B. P53 in turn activates Dkk3, which is a Wnt/beta-
catenin antagonist to down regulate Myc and cyclin D1. As a result, loss of CDK 
activity inactivates Rb-E2F pathway and prevents G1-S transition causing G1/S cell 
cycle arrest (Tudzarova et al., 2010).  
Large-scale proteomics analysis has revealed that the main response to Cdc7 
knockdown was a mild oxidative stress response followed by down regulation of DNA 
synthesis and retinoblastoma (Rb) dephosphorylation, followed by sequential 
stimulation of cell cycle-regulated proteins p53, p21 and p16 in normal somatic cells 
(Mulvey et al., 2010). Also the nucleus and cytoplasm subcellular quantitative 
proteomics revealed the alterations in some significant proteins that are essential for 
DNA replication and cell cycle, which included the tricarboxylic acid cycle (TCA) 
cycle, iron metabolism and protein translation (Mulvey et al., 2013). These results 
indicate that redox signaling pathways are strongly influencing the cell cycle (Mulvey et 
al., 2010, Burhans and Heintz, 2009b).  
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Figure 1-4. The Molecular Architecture of the DNA Origin Activation Checkpoint.  
Inhibition of Cdc7 kinase activity activates a cellular response that is dependent on three 
checkpoint axes coordinated via the cell stress transcription factor FoxO3a. Activation of 
FoxO3a arrests the cell cycle in G1 through activation of the ARF–Hdm2–p53–21 pathways 
which in turn lead to up-regulation of CDKIs: p15 (INK4B) and p27 (CDKN1B). P53 in turn 
activates expression of the Wnt/β-catenin signaling antagonists Dkk3, leading to Myc and 
cyclin D1 down-regulation. The loss of CDK activity inactivates the Rb–E2F pathway and 
prevents the G1–S transcriptional programme. Under oxidative stress, p21 activates the 
transcription factor Nrf2, which detaches from Keap 1 protein and translocates to the nucleus to 
interact with antioxidant response element ARE to trigger antioxidant genes. The loss of Cdc7 
kinase leading to checkpoint activation depends on tumour suppressors that are generally known 
to be inactivated in human tumours and this may explain why cancer cell enter lethal S phase 
leading to specific cancer cell death. Figure originally adapted and modified according to figure 
in (Williams and Stoeber, 2012). 
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1.1.2 ROS Regulation of Mitochondrial Activity 
 
Mitochondria are important organelles that participate in the cell fate. The 
mitochondrial structure consists of inner and outer membrane separated by inter-
membrane space. The inner-membrane surrounds the mitochondrial matrix as numerous 
folds called crista. Notably, this organelle is the main source of energy that is generated 
within the eukaryotic cells from catabolism of carbohydrates (i.e. glycolysis) and fatty 
acids leading to the production of ATPs via oxidative phosphorylation process. In 
addition these organelles are considered to be a main producer of superoxide O2 – and 
participating in ROS activation (Schieber and Chandel, 2014). Most of ROS are 
produced in mitochondrial electron transport chain (ETC) and recently suggested 
complex III (Chandel, 2010). The outcomes of the accumulated superoxide O2 – in 
mitochondrial matrix are different than the outcome in the cytoplasm due to the 
redundancy of iron cluster proteins, which are important for oxidation reduction 
reactions of mitochondria ion transport (Schieber and Chandel, 2014).  
 Mitochondria contain their own DNA (mDNA), which encodes ribosomal, 
transcriptional RNAs, and some proteins. There are two types of the mitochondrial 
proteins depending on their source: proteins that are encoded by the mitochondrial 
genome and translated inside mitochondria and proteins encoded by the nuclear genome 
imported to mitochondria from the nucleus. Among 1000 mitochondrial proteins, 15 are 
encoded by mitochondrial DNA and the rest by nuclear DNA (Wallace, 2012).     
The mitochondrial energy metabolism is a process occurring in the matrix by the 
conversion (i.e. oxidation) of cytosolic pyruvate, which is the outcome of glycolysis; 
and fatty acids into acetyl CoA, which in turn is converted to CO2, flavin adenine 
dinucleotide hydrogenase 2 (FADH2) and nicotine adenine dinucleotide hydrogenase 
(NADH) by the citric acid cycle (TCA).  In the case of oxidative phosphorylation 
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process, the inner-membrane contains more than 70% of oxidative phosphorylation 
proteins that are responsible for the transport of pyruvate and fatty acids between the 
mitochondria and the cytoplasm. The NADH and FADH2 high energy electrons transfer 
to the inner-membrane and after a series of reactions they are converted into molecular 
oxygen and release energy for ATP synthesis (Cooper and Hausman, 2004).  
In cancer cells, Otto Warburg (a Nobel prize laureate in physiology in 1931s) observed 
that tumour cells shift their energy metabolism from oxidative phosphorylation to 
aerobic glycolysis in the presence of oxygen, which is known as the Warburg effect, 
thus producing a large amount of lactate. Several hypotheses have been postulated for 
the Warburg effect such as; cancer cells adapting to a low oxygen environment (i.e. 
hypoxia) for survival, oncogenes reducing the amount of mitochondria in order to avoid 
apoptosis by shutting them down, or because the glycolysis process is the main event in 
the normal cell proliferation (Lopez-Lazaro, 2008). Mitochondrial disorders are a cause 
of a number of diseases including cancer, neurodegenerative diseases and type 2 
diabetes (Patti and Corvera, 2010). There is no definitive evidence to support that the 
Warburg effect occurs due to the mitochondrial defect. For instance, in cancer cells, 
enzymes such as phosphoglycerate mutase 1 (step 8 in glycolysis pathway) have been 
found to alter their expression and shift the metabolism to different biosynthetic 
pathways, such as pentose phosphate and serine biosynthesis pathways to promote 
cancer growth due to the loss of p53 (Vander Heiden et al., 2009, Hitosugi et al., 2012).  
Wallace, 2012 discussed in his review paper (Wallace, 2012) that, functional 
mitochondria are important for cancer cell and that the mutation in mDNA is essential 
for remoulding the bioenergetics and biogenesis mitochondrial states to allow  the 
survival of cancer cells. 
Redox regulation of cytochrome c to prevent apoptosis has been found to occur due to 
the increase of glucose metabolism and the Warburg effect leading to tumour survival in 
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cancer and neuron cells (Vaughn and Deshmukh, 2008, Boland et al., 2013). Increased 
levels of ROS change mitochondrial function, leading to disturbance in ETC and change 
of metabolism. Oncogenes that induce ROS support tumorigenesis via increasing the 
stability of HIFα hypoxic factor, increased oxidative DNA damage, increased calcium 
flux levels, inactivating the growth factor inhibitors the phosphatases, and activating the 
transcription factors Nrf2 and NF-κB (Hamanaka and Chandel, 2010, Schumacker, 
2006, Sena and Chandel, 2012, Wheaton and Chandel, 2011).   
Mitochondria are normally regulated by mechanisms which include mitophagy, fusion, 
fission and biogenesis (Boland et al., 2013). Fusion helps mitigate stress by mixing the 
contents of partially damaged mitochondria as a form of complementation. Fission is 
needed to create new mitochondria, but it also contributes to quality control by enabling 
the removal of damaged mitochondria and can facilitate apoptosis during high levels of 
cellular stress. Disruptions in these processes affect normal development, and they have 
been implicated in neurodegenerative diseases, such as Parkinson’s, Alzheimer’s, and 
Huntington’s diseases (Detmer and Chan, 2007, Boland et al., 2013, Hales, 2004).  
Endoplasmic reticulum (ER) plays a key role in fission and fusion regulation. For 
example, in fission, ER regulates division of mitochondria sites (Friedman et al., 2011). 
Mfn2 protein, which is a fusion protein, works as a connector between mitochondria 
and ER in the aim to absorb calcium from ER (de Brito and Scorrano, 2008).  It has 
been found that, in yeast, mitochondria may bind to the ER and the cellular cortex for 
changing organelle cellular location (Lackner et al., 2013). The rates of fission and 
fusion are also coordinated with the cell cycle (Boland et al., 2013). Mitochondrial 
fusion has been reported to be required for G1/S transition and S phase entry in the 
presence of cyclin E (Mitra et al., 2009).  
Markedly, the signaling pathways regulating fission and fusion are also involved in 
types of cellular stress that are associated with cancer such as the changes in energy 
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levels, cell cycle signals and hypoxia (Boland et al., 2013). For example, UV light 
activates OPA1 fusion protein to increase fusion (hyper-fusion), produce ATP and 
prevent apoptosis (Tondera et al., 2009). In contrast, fission leads to mitochondrial 
membrane depolarization, disturbance in H+ flow around the inner-membrane leading to 
membrane loss and reduction in Ca+ mitochondrial uptake. The depolarization of 
mitochondria in turn leads to prevention of cytochrome c being released in the 
cytoplasm as well as to apoptosis. Moreover, in HeLa cells, ROS induce mitochondrial 
depolarization and degradation by autophagy (i.e. mitophagy) depending on 
mitochondrial morphology (Wang et al., 2012). 
Surprisingly, mitophagy is not only important for cancer cells but also for the stromal 
cells nearby to these cells. For example, Bonuccelli and his collages (Bonuccelli et al., 
2010) have detected that, the stromal fibroblasts that are neighbouring to the breast 
cancer epithelial cells shift their metabolism to glycolysis due to the absorption of H2O2 
generated from the neighbouring transformed cells. As a result, the mitophagy in the 
normal fibroblast cells is induced switching their metabolism to produce lactate that is 
important to feed cancer cells. This process is called ‘the reverse Warburg effect’ 
(Wallace, 2012).   
 
1.2 Intracellular Signaling Pathways of Nrf2, FoxO3a, HIFs and Arginine/Proline 
are regulated by ROS	  
 
1.2.1 Nrf2 Signaling: Under oxidative stress, the activation of the transcription factor 
nuclear factor erythroid 2-related factor 2 protein (Nrf2) via disassociation from its 
inhibitor protein Kelch-like ECH-associated protein 1(Keap1) leads to increase in 
production of cancer cells antioxidant proteins (Sporn and Liby, 2012, Guo et al., 2014, 
Chun et al., 2014).   
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Normally, Nrf2 is located in the cytoplasm and is detected from degradation by 
interaction with Keap1. However, increased ROS oxidize Keap1 at its cysteine residues 
leading to dissociation and preventing degradation of NRF2. As a result, Nrf2 
translocate to the nucleus and form heterodimers with the transcription factor MAF 
protein, and interact with the antioxidant responsive element (ARE) at the regulatory 
regions of antioxidant genes (Chun et al., 2014, Schieber and Chandel, 2014, Dinkova-
Kostova et al., 2002, Nguyen et al., 2000, McMahon et al., 2003, Numazawa et al., 
2003, Itoh et al., 1997). This leads to activation of stress response genes such as haem 
oxygenase 1 (HMOX1), which is a vital enzyme for haem catabolism (Frezza et al., 
2011, Adam et al., 2011).   
High levels of ROS are an activator for Nrf2. It has been found that mutated Keap1, PI3 
and ERK MAP kinase signaling pathways may be involved in Nrf2 activation as well 
(Jaramillo and Zhang, 2013, Je et al., 2012, Wang et al., 2008a). Recently, in mice, 
oncogenes involving Myc, Kras and Braf were shown to enhance Nrf2 expression in 
order to control the ROS antioxidant production and detoxification (DeNicola et al., 
2011). On the contrary, the Nrf2 defect in cancer cells may lead to increased oxidative 
stress, and cellular damage (DeNicola et al., 2011, Schieber and Chandel, 2014).  
It is estimated that Nrf2 has the ability to activate more than 100 antioxidant genes (Itoh 
et al., 1997, Rushworth et al., 2012). However, it has been observed that deletion of 
specific antioxidants such as peroxiredoxins Prdx1 may not elevate ROS to the level 
that causes the damage in cancer cells and instead may enhance tumorigenesis 
(Neumann et al., 2003, Cao et al., 2009). Under normal conditions, Nrf2 can play a 
crucial role as a cyto-protective agent against the cellular injury and oxidative damage 
due to its ability to stimulate the cellular antioxidants (Rushworth et al., 2012). Nrf2 
proteins also adapt their localization according to the cellular redox situation.  
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1.2.2 P53 and ROS: There are massive groups of proteins coordinating with ROS for 
cells growing and differentiation. For example, a tumour suppressor such as p53 can act 
as an antioxidant to prevent ROS formation above the levels that encourage the signals 
of proliferation (Sablina et al., 2005). P53 also has been found to up-regulate a set of 
genes that generate antioxidant products such as the mitochondrial superoxide 
dismutase 2 (SOD2), glutathione peroxidase 1 (GPX1) and aldehyde dehydrogenase 4 
family member A1 (ALDH4A1) (Tan et al., 1999, Hussain et al., 2004, Yoon et al., 
2004).  
1.2.3 FoxO3a Signaling: Previous work from our group (Tudzarova et al., 2010) 
revealed a particular importance of FoxO3a protein in signaling leading to cell cycle 
arrest following Cdc7-depletion of human fibroblasts. Fork head box O (FOXO) is a 
tumour suppressor and a transcription factor has been found to be regulated by oxidative 
stress by SOD2, upon which it translocates to the nucleus (Furukawa-Hibi et al., 2005) 
and controls the antioxidant expression genes.  
It‘s role in cell cycle arrest via checkpoint activation, DNA repair and apoptosis (Figure 
1-4) has been described in details by Tudzarova and Stoeber (Tudzarova et al., 2010). In 
addition, FoxO3a has been found to participate in negative regulation of hypoxia-
inducible factor 1 (HIF1) (Dansen and Burgering, 2008, Ferber et al., 2012). Thus, 
FOXO and p53 negatively regulate the ROS production. 
1.2.4 HIFs Signaling: ROS normally support the metabolic stress in order to maintain 
mitogenic signals when tumour cells exceed their blood supply. As a result, tissue 
response to hypoxia leads to stabilization of HIFs (Semenza, 2012). HIFs mediate the 
effect of ROS on angiogenesis, which is very important for tumour growth (Krock et 
al., 2011). These proteins are heterodimers consisting of two alpha (HIFα) and beta 
subunits  (HIFβ). Under normal conditions, the oxygen sensitive subunit alpha (HIFα) is 
hydroxylated by prolyl hydroxylases (PHDs) at the proline residues to be recognized by 
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E3 ubiquitin ligase, pVHL and targeted for proteasomedegradation. Under hypoxia, 
high ROS levels, proline residues of HIFα are not targeted by PHDs for degradation, 
resulting in HIFα translocation to the nucleus and dimerizes with HIFβ to regulate the 
cellular adaptation to hypoxia and activation of the pro-angiogenic genes (Miyata et al., 
2011, Semenza, 2012, Kaelin and Ratcliffe, 2008). Thus, tumorigenesis of certain 
cancers can be promoted via stabilization of HIFs due to increase levels of ROS (Gao et 
al., 2007, Ma et al., 2009). 
1.2.5 Arginine/Proline Metabolism: Besides their role as tumour suppressors 
Arginine/proline metabolism, have been found to influence ROS regulation (Phang et 
al., 2012). Mitochondrial ROS translocate to the cytosol and target proline cycle 
catalytic enzyme proline oxidase (POX)/proline dehydrogenase (PRODH) to initiate 
ROS-responsive signaling pathways (Donald et al., 2001, Maxwell and Rivera, 2003, 
Kim et al., 2007, Liu et al., 2005). Interestingly, POX/PRODH were reported to 
significantly inhibit tumour growth in immunodeficient mice, and this enzyme may thus 
be considered as a tumour suppressor (Liu et al., 2010, Liu et al., 2009). This also 
explains why ROS-dependent POX/PRDH pathways regulate pathways such as p53, 
AMPK and PPARγ and its importantance for mitochondrial mitophagy and apoptosis in 
response to oxygen deprivation (Phang et al., 2012).  Proline can also be incorporated in 
many cancers as collagen (Priest and Davies, 1969, Kao et al., 1986). 
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1.3 ROS in Pathology  
 
Pathways responsive to ROS are very important for cellular function and thus cellular 
ROS levels are involved in pathogenesis of a number of diseases.  
 
1.3.1 Role of ROS with Cancer 
 
Cancer refers to a large group of different diseases resulting in uncontrolled cell growth. 
The origin of the word cancer is credited to the Greek physician Hippocrates (460-370 
BC) (Mukherjee, 2010). In cancer cell, the growth mechanisms are permanently 
activated even in the absence of mitogens, thus sustaining persistent proliferation 
(Harbour and Dean, 2000, Hanahan and Weinberg, 2011). Markedly, cancer cells 
induce elevated ROS generation from the endoplasmic reticulum, mitochondria and the 
cytoplasm from NADPH oxidase (Cairns et al., 2011). High level of ROS may cause 
genomic instability and lead to tumorigenesis (Figure 1-5) (Szatrowski and Nathan, 
1991). However, tumorigenesis requires the avoidance of cell death and therefore 
cancer cells usually produce an equal amount of antioxidant to keep redox balance 
(Gorrini et al., 2013, Trachootham et al., 2006, Nogueira et al., 2008). Moreover, 
regardless of the high levels of antioxidants within cancer cells the ROS responsive 
signaling pathways are activated presumably due to their physical proximity to ROS 
production sources (Schieber and Chandel, 2014). Inhibition of NF-kB prevents 
accumulation of Nrf2 and prevents chemotherapy resistance in acute myeloid leukaemia 
(Rushworth et al., 2012). 
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Figure 1-5. ROS in Normal and Cancer Cell Regulation.  A. ROS affects important 
pathways that participate in cellular metabolism, angiogenesis, growth, survival and 
proliferation. B. Cancer cells produce high level of ROS and promote tumorigenesis. 
Oncogenic proteins such as HIFs, PI3K, MAP kinases and NF-κB under hypoxia and in 
the absence of p53 lead to increased redox levels and rapidly enlarging tumours. At the 
main time, Nrf2 participates in the elimination of high level of oxidative stress that lead 
to establishment of cell apoptosis via controling sets of important cellular antioxidants 
including SODs, GSH, GPXs and PRXs (Schieber and Chandel, 2014). 
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1.3.2 Role of ROS in Diabetes, Insulin Resistance and Neurodegeneration 
  
Diabetes is mainly characterized by excessive amounts of glucose and fatty acids in the 
cells leading to several physiological damages. High glucose levels lead to increased 
oxidative stress via activation of several processes such as the hexosamine pathway, 
oxidative phosphorylation, glyceraldehyde autooxidation and sorbitol production 
(Robertson, 2004). In addition, accumulation of fatty acids might cause lipotoxicity 
leading to failure of several organs (Brookheart et al., 2009, Alfadda and Sallam, 2012).  
In adipocytes, saturated fatty acids, generation of ROS and NF-κB activation can result 
in inflammation (Yeop Han et al., 2010). ROS play a central role in insulin resistance as 
it has been found that pharmacological inhibition of ROS can affect insulin resistance 
state (Houstis et al., 2006). This effect has been suggested to occur by the regulation 
and translocation of Forkhead transcriptional factor 1 (FOXO1) from cytoplasm to the 
nucleus enhancing insulin resistance via gluconeogenesis (Kaneto et al., 2010).  
It is clear that ROS and oxidative stress are of major physiological and pathological 
relevance to the cells. The role of ROS in neurodegenerative disease such as Alzheimer 
and Parkinson’s is of a particular and increasing interest (Dumont and Beal, 2011, 
Campos et al., 2014).   
Thus any new information on the cellular processes during oxidative stress is potentially 
of high clinical relevance based on the ROS involvement in pathology and aetiology of 
a number of diseases. It is thus clear that there is an urgent need for exhaustive analysis 
of changes in the cellular proteome under oxidative stress. 
 
 
 
	   46 
1.4 The Use of Subcellular Quantitative Proteomics to Study ROS and Oxidative 
Stress: Bottom-up and Top-down Strategies 
 
Proteomics is a science that describes the characterization of all protein phenotypes in a 
living system including protein amount, form, modification and location (Godovac-
Zimmermann and Brown, 2001). The proteomics methodology in study of a cellular 
system involves parallel investigation of proteome phenotype alterations with an 
ultimate attempt to explain the cause of these changes (Godovac-Zimmermann and 
Brown, 2003). Mapping of all cellular proteins is not sufficient to understand the 
dynamics of proteins in vivo as it basically catalogues the proteins without giving a 
functional explanation. Thus, emergence of the awareness of functional proteomics in 
order to describe and quantify the spatial and temporal distribution and interaction 
between different protein networks (Godovac-Zimmermann and Brown, 2001) is seen 
as a paradigm shift in protein science. 
Determination of protein abundance, localization and modification are amongst the 
most interesting goals in post-genomic biology.  Classical methods of protein chemistry 
such as western blot or immunoprecipitation helped to reveal a large number of cellular 
protein interactions but they are not sufficient for the study of the molecular mechanics 
of the entire proteome. In addition, the correlation between mRNA and protein 
abundances in the cell has been reported to be notoriously poor	   (Anderson and 
Seilhamer, 1997, Gygi et al., 1999b) stressing the need for the investigation at protein 
level.  Finally, the crucial protein regulation processes, post-translational modifications 
such us phosphorylation, acetylation and glycosylation can only be studied at the 
protein level.  
Methodologically, current proteomics is driven by the extensive development of mass 
spectrometry (Walther and Mann, 2010). There are two fundamental strategies currently 
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used for protein identification and characterization by the use of MS-based proteomics: 
the first one is called bottom-up or ‘peptide levels’ proteomics, which depends on the 
specific mass of the tryptic peptides and top-down ‘protein levels’ proteomics, where 
protein characterization relies on the unique molecular mass of the whole protein 
followed by “in-situ” MS fragmentation. Both of these approaches have advantages and 
disadvantages as described in Table 1-1. Although bottom-up proteomics uses peptide 
as surrogates for proteins, it is more popular and encompasses around 90% of all recent 
proteomics experiments due to current technical developments in the hybrid mass 
spectrometry field. Among the disadvantages of top-down proteomics is the fact that 
insoluble proteins such as membrane proteins are difficult to handle and require the use 
of detergents which in turn interferes with MS analysis.  Other limitations, such as often 
huge masses of the intact proteins as well as different post-translational modifications 
that the proteins normally undergo can eliminate the MS ability to correctly identify 
those proteins. These reasons make bottom-up method more suitable for the analysis of 
complex protein samples (Wehr, 2006). 
Bottom-up proteomics can also refer to the shotgun proteomics. This approach ensures a 
high-throughput, on-line and highly confident protein identification (Walther and Mann, 
2010) making it often a method of choice for large scale proteomics experiments. 
With this strategy, which uses peptides as protein surrogates, protease enzymes such as 
trypsin and chymotrypsin are used for protein digestion. The high specificity of trypsin 
and tryptic peptide length is a crucial factor for MS detection ability and the use of 
trypsin has great advantages for bottom up proteomics. Trypsin cleaves the peptides at 
C-terminus of arginine (Arg) and lysine (Lys) and most of tryptic peptides are 4 to 40 
amino acids long.  These cleavage method has a huge commercial advantages as trypsin 
is cheap, easy to produce, peptide mass is easy to predict due to trypsin high specificity 
and tolerance of different concentrations and conditions. Trypsin can work well with 
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either native or denatured proteins. However, there are several limitations with trypsin 
such as, the endogenous ability to cut a peptide sequence at Arg or Lys at the 
consecutive positions and incomplete digestion especially at the side close to peptide C-
terminus. Tryptic peptides that are outside the MS size range cannot be detected which 
can result on the loss of the information for some proteins.  The biological nature of 
trypsin is known to require slightly basic and mildly denaturing experimental conditions 
(Lovric, 2011). The most common form that is used in proteomics sample preparation is 
so-called trypsin gold from Promega, which has been modified to be more stable and 
resistant to autolysis.  
Peptide sample generation for MS driven proteomics analysis using trypsin can be 
achieved either by in-gel or in-solution digestion at an optimal temperature for trypsin 
of 37oC.  In fact, the use of trypsin with any of these approaches (i.e. in solution or in 
gel) can be varying according to experimental design, amounts, concentrations and 
nature of the sample (Lovric, 2011, Beynon and Bond, 1989, Mann et al., 2001, 
Rosenfeld et al., 1992, Shevchenko et al., 1996, Rice et al., 1977). The gel approach, 
which was the most popular at the early beginning of proteomics, such as two-
dimensional gel (2-D) gel was widely used (O'Farrell, 1975). However, disadvantages 
such as low resolution, protein dynamic range, long separation time, insufficient protein 
separation and inability to separate membrane proteins limited the use of 2D gel in 
proteomics laboratories today (Ong and Mann, 2005, Wilkins et al., 1996, Corthals et 
al., 2000, Anderson and Anderson, 1998). 1D SDS-PAGE (Shevchenko et al., 1996) has 
overtaken 2D (Au et al., 2007) gels and is wildly used today to reduce sample 
complexity prior to LC-MS/MS experiment. 
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  Bottom-up Top-down 
Advantages • Widely used for identification and 
characterization of proteins at their 
peptides level. 
 
• Can be applied with very complex 
samples. 
 
• It uses HPLC that has reversed 
phase that uses solvents are 
compatible with ESI. 
 
 
• Can be used with online fully 
automated nano-LC-MS/MS. 
 
• Compatible with most labeling 
methods. 
 
• Software and bioinformatics 
analysis tools are available. 
 
• Complete access to intact proteins 
sequence. 
 
• Ability to locate post- 
translational modifications. 
 
• Less time for sample preparation 
as there is no need for digestion 
step. 
 
 
   
Disadvantages 
 
• Identified fraction of total peptide 
population of given protein which 
give information relay on part of 
the proteins sequence. 
 
• Sometime limited sequence 
coverage can lead to the loss of 
much information about PTMs 
and protein isoforms. 
 
•  Limited information about low 
abundant peptide in mass spectra 
dominated by high abundant 
spectra.  
 
• Long running time within 
chromatography for very complex 
mixtures. 
 
• Need to narrow chromatographic 
peak widths to get adequate 
amount of information and that 
can be achieved by the use of 
nano-LC. 
• Sometime it is a challenge to 
determine ions masses and 
analyse the very complex spectra 
with multiply charge ions.  
 
• Not widely used compared to 
bottom-up. 
 
• Limitation in terms of instrument. 
Only coupled with relatively 
expensive MS such as FT-ICR. 
 
• It has not worked with any protein 
larger than 50KDa. 
 
• Coupled with electron-transfer 
dissociation fragmentation 
method (EDT) that needs long 
time for ion accumulation, 
activation and detection.  
 
• Protein dissociation behaviour is 
less understood.  
 
 
• Bioinformatics analysis tools for 
top down just recently improved. 
 
  
 
Table 1-1. Advantages and Disadvantages Bottom-up and Top-down Proteomics Approaches 
(Wehr, 2006). 
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1.4.1 Quantitative Proteomics and Labeling Strategies   
 
MS-based quantitative proteomics is a crucial approach that allows us to differentiate 
and quantify between protein levels under different conditions. However, the MS 
intensity peak remains a bad indicator of protein amounts within the sample. MS-based 
protein quantification can be absolute or relative. Absolute quantification means that 
samples are determined directly in absolute values in the presence of internal proteins 
labeling standard for each protein while relative quantifications rely on recognition of 
the changes in protein levels relative to another protein abundance (Ong and Mann, 
2005); Yet, the ultimate goal of quantitative proteomics is to achieve absolute 
quantification of the protein abundance (Kito and Ito, 2008). Also, it is clear that 
absolute quantification requires more time and is a costly undertaking with complex 
samples.  
The relative quantification of a proteome can be achieved by two methods: label-free 
and isotopic labeling (Figure 1-6). Currently, the use of SILAC or stable isotope 
labeling of amino acids in cell culture is considered as one of the most popular 
nonradioactive labeling approaches in the quantitative proteomics field. For the SILAC 
method, the proteins of two cellular states (i.e. treated and non-treated) are fully labeled 
by incorporation of essential amino acids such as arginine (Arg) and/or lysine (Lys) 
with heavy 13C or 15N or both and light 12C or 14N followed by digestion with trypsin of 
mixed cell samples. The mixture of heavy and light labeled cells remains 
indistinguishable until analysed by MS and by a suitable software package such as 
MaxQuant (Cox et al., 2009, Cox and Mann, 2008). The double charge intensity peak of 
the isotopic peptide for heavy lysine (Lys 6) is shifted by 6 Da from the light one (Lys 
0), which is easy to distinguish by MS (Walther and Mann, 2010, Ong et al., 2002).  
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The most common advantages of using SILAC in quantitative proteomics are time 
saving, low contamination levels (i.e. keratin), reduced false negative results and 
quantification errors as sample combining is achieved at the early stage of the 
experiment.  
There are other often used labeling strategies such as ICAT and iTRAQ. ICAT  (isotope 
code affinity tag) is a chemical labeling for relative quantification developed in 1999 in 
the Aebersold’s laboratory (Gygi et al., 1999a). The labeling includes introduction of a 
chemical tag (biotin) to particular residue (cysteine) to all proteins of the target 
population and mixing of the samples is carried out at the peptide level. However, non-
specific binding to the tag and incomplete proteome coverage has limited the wider use 
of this technique (Zhou et al., 2002).  iTRAQ is another type of chemical labeling that 
can be applied for relative and absolute quantifications with  the tag normally 
introduced to the N-terminus and the side-chain of the peptides. Tag differentiations are 
carried out at MS analysis level (Ross et al., 2004).  
The choice between different labeling types depends on the sample itself. SILAC use 
has been extended from cell lines to microorganisms and vertebrates (Kirchner and 
Selbach, 2012). However, some cell types are not metabolically stable with introduction 
of the labels or cannot tolerate the effect of the treatment. In these cases the alternative 
labeling types or label free quantitation are better choices. 
 
1.4.2 Subcellular Organelle Proteomics 
 
In order to obtain better understanding of the cellular organization and function the 
proteomics field recently concentrated on subcellular organelles. Since the dynamic 
entities of organelles such as proteins move from one compartment to another to 
accomplish their specific function, it is important to try to understand the role of 
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proteins at various cellular locations (Cox and Mann, 2011).  Organelle separation 
methods such as density-based methods already used since the 50s are often used today 
in addition to various methods for organelle enrichment.  
Following organelle separation or enrichment the major experimental step of sub-
cellular proteomics is to quantify enriched organelle fractions of interest and compare it 
to non-enriched fractions. The crucial task is to differentiate between true permanent or 
temporary organelle resident proteins and to identify “background proteins” that in turn 
can indicate the secondary localizations of each protein.  
Various methods and strategies for control of the process are described in details by 
Qattan and Pinto work (Qattan et al., 2010, Qattan et al., 2012, Pinto et al., 2014). 
 Databases such as Gene Ontology helps to classify proteins according to their 
biological process, localization and molecular function giving useful overall but not 
definitive estimate of the data (Cox and Mann, 2011, Gauthier and Lazure, 2008, Brunet 
et al., 2003). 
There is increased evidence that many proteins (at least 50%) are not exclusive to one 
organelle and are present in several locations (Drissi et al., 2013, Cox and Mann, 2011, 
Qattan et al., 2010). Recent investigations using a SILAC strategy for spatial 
proteomics quantitative changes in protein localization under diverse conditions showed 
that multiple distribution of proteins could be crucial for cellular function (Drissi et al., 
2013, Mulvey et al., 2013, Pinto et al., 2014). Surprisingly, SILAC labeling of MCF7 
breast cancer cells exposed to the estradiol showed that there were significant changes 
of the proteins distribution between nucleus and cytoplasm compared to the total cell 
lysate, concluding that the spatial proteins distribution is an important feature of cancer 
(Pinto et al., 2014).  
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Figure 1-6. Work Flow of the Comparison among the Different Labeling Strategies in 
Quantification Proteomics. There are two main labeling approaches: isobaric labeling and 
label free. Isobaric labeling consists of metabolic labeling such as SILAC and chemical labeling 
such as iCAT and iTRAQ. Green and blue boxes represent an example of two states that are 
compared.  In the SILAC approach the isotopic labels are initiated in the cell culture, samples 
are combined at the protein extraction stage and they continue together through all the steps of 
the analysis. In the iCAT method, proteins are extracted in parallel and combined at the peptide 
level. In iTRAQ the tag is introduced once the samples are digested into peptides. For label free 
method data can be combined at any stage and the data are obtained from MS spectral counts or 
ion current information. Modified according to figure in (Ong and Mann, 2005).  
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1.4.3 Overview of Mass Spectrometry based Proteomics  
 
Mass spectrometry is a powerful tool for measuring the mass of a molecule by 
measuring the mass-to-charge ratio (m/z) of ions. Mass spectrometry is widely used in 
biology, chemistry and physics. It is an attractive analytical method used in proteomics 
for studying protein roles, functions and modifications. Mass spectrometer (MS) relies 
on accelerating the ionized charged-molecules in vacuum with high energy under high 
atmospheric pressure encouraging them to go through a electric and magnetic field that 
allows them to be detected and the generated information appears as spectral data on the 
computer screen.    
MS consists of three crucial parts and each part plays an important role within the 
instrument: ionisation source, mass analyser and detector (Figure 1-7A). The most 
popular ionization sources that are widely used in proteomics laboratories are 
electrospray ionization (ESI) and matrix assisted laser desorption ionization (MALDI) 
(Figure 7B and 7C) (Aebersold and Mann, 2003). MALDI and ESI are considered to be 
“soft” ionization techniques.  Soft ionization is especially useful for generation of ions 
from proteins since it overcomes the tendency of these molecules to fragment when 
ionized. (Guerrera and Kleiner, 2005). MALDI generally ionizes the samples out of dry 
solid phase using laser pulses and it is extensively applied with relatively limited 
peptide mixtures whereas ESI ionizes the samples out of solution. ESI is often coupled 
with liquid chromatography making this method highly efficient for analysis of 
complex samples and high throughput proteomics.  
The exact desorption/ionization mechanism for MALDI is not known but it is generally 
believed that MALDI causes the ionization and transfer of a sample from the condensed 
phase to the gas phase via laser excitation and ablation of the sample and matrix.  
MALDI (Figure 1-7C) analysis includes the co-crystalization of the sample with an 
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organic matrix such as sinapinic acid that coats a metal board.  The matrix is then 
stimulated through the pulsed laser light such as, UV light, leading to vaporization and 
desorption of the sample from the surface (Lovric, 2011, Guerrera and Kleiner, 2005, 
Yates, 2004). As the consequence of using laser pulses in MALDI the ions are 
generated as packages rather than a continuous beam and that might require a specific 
analyser that is able to measure all ions without considering their mass range or trap 
them for subsequent analyser, usually time of flight analyser (TOF).  
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Figure 1-7. The Anatomy of the Internal Parts of a Mass spectrometer. A. Shows the basic 
structure of a mass spectrometer, while B. and C. represent the sample introduction process to 
the MS via electrospray ionization (ESI) and matrix-assisted laser desorption (MALDI). 
Modified according to figure in (Aebersold and Mann, 2003). 
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In ESI (figure 1-7B) the ionization procedure is normally accomplished by spraying the 
electrically fine vapored ions under atmospheric pressure with a low flow rate. Samples 
are introduced to ESI through a charged needle held at high electric potential (2.5-4kV). 
This allows sample molecules to diffuse from charged droplets. Then, between needle 
and sampling cone, the evaporation of the solvent reduces the droplets size and 
increases the charge density, which in turn increases charges collision. This collisions 
lead to desorption of sample ions and the reduction of the droplets size until it becomes 
almost one ion. The protein ions normally accept positive charge, which allows them to 
be easily dragged and accelerated by negatively charged ion magnetic source.  Coupling 
the ESI with special analysers can lead to fragmentation of the selected precursor ion 
via a method called collision-induced dissociation (CID).  Particular improvement in 
ESI mass spectrometry occurred with Nano spray technology developed by Mann and 
Wilm where the ESI needle is connected to a Nano-flow reverse phase liquid 
chromatographic system (RP-HPLC) allowing the initial fractionation of the peptide 
samples with low flow rates (50nl/min) in order to perform better MS analysis (Ho et 
al., 2003, Fenn et al., 1989, Pitt, 2009, Mann and Wilm, 1995). 
In mass spectrometry different analysers have been used such as, ion trap, time-of-flight 
(TOF), quadrupole, and Fourier transform ion cyclotron (FT-ICR) analysers. Each 
analyser depends on special theory and principles with specific advantages and 
disadvantages. For example, an ion trap analyser traps and centres the ions for a certain 
period of time (time interval) at cylindrical volume storage to allow easily insertion of 
the ions for further processing. There are many different ion traps such as, linear, two or 
three-dimensional trap. The ion trap is a robust analyser, reliable, sensitive, and not 
expensive. FT (Fourier transform) analyser traps the ions under a high vacuum and 
magnetic field. It is an accurate, sensitive tool and gives a high resolution with the 
dynamic range of quantitation of at least 5 orders of magnitude. TOF (time-of-flight) 
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analyser separates the ions depending on there flying time that is affected by the m/z of 
the molecules (m/z).  
Linear quadruple ion trap (LTQ) is a mass analyser (Figure 1-8) that can be used as 
collision cell for peptide ions fragmentation.  It consists of four rods that restrain ions 
radially and electro-static potential on the end of the electrodes that restrains ions 
axially (Douglas et al., 2005).  
Each analyser can be standing alone or together in tandem increasing the productivity of 
the MS. In MALDI the ion source can be coupled with a TOF analyzer or TOF-TOF 
instrument, which is able to fragment the ions via a collision cell. Usually, ESI is 
connected with an analyser such as, ion trap, triple quadrupole (linear) trap, quadrupole 
TOF and FT-MS.  
Recently, a FT-MS instrument has been rapidly developed and notably employed in the 
proteomics field due to the machine’s ability to provide a wide mass range analysis, its 
high resolution and sensitivity. The advantages of these instruments are accuracy and 
maximum mass resolution that are accomplished even for a small amount of ions. These 
privileges allow FT-MS and Orbitarp to outperform other mass spectrometers in the 
large scale proteomics field (Perry et al., 2008).  
Two major characteristics of the MS analysis are mass accuracy and mass resolution. 
The mass accuracy is the ratio between false m/z to the true m/z in part per million 
(ppm). While resolution means ability to segregate differences between two peaks with 
highly similar m/z. High accuracy can remarkably determine an element’s formula, 
which can be used as filters to define the identity of the compounds. This is important 
because it is impossible to achieve mass quantitation of a peak accurately if the target 
molecules are not sufficiently determined (Perry et al., 2008).  
The most of mass spectrometric experiments currently used in proteomics are consisting 
of two or more MS experiments, called tandem experiment (MS/MS). The first MS 
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usually determine the mass/charge for the initial molecules known as parent or 
precursor ions while the second MS experiment fragments these parent ions producing 
new daughter ions (Walther and Mann, 2010). The advantage of a tandem experiment is 
that it allows protein quantification and subsequently the reliable identification based on 
peptide sequence information. 
In this study, we have used a classic ‘LTQ-Orbitrap hybrid’ mass spectrometer (figure 
1-8) that has been developed by Thermo-Fisher scientific (for further information about 
the Orbitarp, see the references (Scigelova et al., 2011, Perry et al., 2008) and related 
references).   
Orbitrap is an ion trap analyser that consists of a vacuumed chamber that contains inner 
and outer spindle electrode, with high electrostatic field. The electrostatic field leads to 
trapped ions and makes them move in spiral motion around the spindle with different 
frequencies. The image current of the trapped ions can be detected and converted into a 
spectrum by Fourier transform (FT). The Orbitrap has the ability to offer high mass 
accuracy with high resolving power (Makarov, 2000, Hardman and Makarov, 2003, 
Scigelova and Makarov, 2006). The detected mass accuracy of the Orbitrap from 
complex peptide mixtures is normally less than 2 ppm. However, this mass accuracy has 
been subsequently improved to be less than 1 ppm (Olsen et al., 2005). Moreover, the 
Orbitrap outer electrode can work as a detector making the Orbitrap more practical and 
faster for ion fragmentation. Coupling an Orbitrap with a linear trap increased the LTQ-
Orbitrap’s sensitivity (figure 1-8).  
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Figure 1-8. The Anatomy of the Internal Parts of ‘LTQ-Orbitrap Hybrid’ Mass 
Spectrometry. Samples are injected tangentially via charged needle to the electrospray 
ionization source (ESI). The charged ions go through a quadruple ion trap, which increases the 
ion’s speed in the presence of different pressure from atmospheric conditions and accelerates 
them toward the linear ion trap. |The Liner ion trap reduces the speed of the ions and stores 
them until enough ions are accumulated. This is followed by injection to the C-trap, which is the 
last quadruple that compresses the ions and dampens their energy before sending them to the 
Orbitrap with constant speed with an accurate direction (Scigelova and Makarov, 2006, Perry et 
al., 2008). 
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1.4.4 Interpretation of the Quantitative Proteomics data and Spatial Razor Peptide 
Approach 
 
Shotgun-proteomics is based on tandem MS/MS experiment or parent ion fragmentation 
by collision induced dissociation (CID) in the presence of inert gas (i.e. nitrogen, argon 
or helium).  
The information of the peptide sequence generated from the tandem MS spectra consists 
of the fragments x, y or z if the charge is maintained on the C-terminus or by a, b, or c if 
the charge is retained on the N-terminus. By determination of the mass difference 
between C- and N- ion peaks the peptide sequence can be generated. Then, the obtained 
peptide sequences are compared to protein database that is mostly generated from 
genomic/protein sequence database using a computer algorithm to match peptides to 
their target protein and control the false discovery rate. The most popular peptide search 
engines that uses database matching for peptides and the assembling of proteins are 
Mascot (Perkins et al., 1999), SEQUEST (Eng et al., 1994)  or X!Tandem (Craig and 
Beavis, 2003, Craig and Beavis, 2004). The software generates a list of detected 
proteins within the sample, as it is impossible to check the predictability of huge 
amount of data set manually. Software such as MaxQuant can be used coupled with its 
own search engine such as Andromeda followed by the evaluation of the analysis to 
assemble the protein groups and quantify them between the different conditions (Cox 
and Mann, 2008, Cox et al., 2009, Cox et al., 2011).  
The spatial distribution of the proteins between organelles can be detected by the use of 
mathematical formulation of the subcellular spatial razor. The major need for the 
development of this approach is the fact that under a specific cellular perturbation 
protein response may show both change in total abundance and in their compartmental 
spatial distribution such as between nucleus and cytoplasm. The spatial razor model 
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(figure 1-9) assumes that a given protein can be present in the nucleus (n) and 
cytoplasm (c) for both stimulated (s) and unstimulated cells (u) (Baqader et al., 2014, 
Pinto et al., 2014, Mulvey et al., 2013). Correspondence abundance of each protein is 
scattered between protein abundance in nucleus stimulated (An,s), protein abundance in 
nucleus unstimulated (An,u), protein abundance in cytoplasm stimulated (Ac,s) and 
protein abundance in cytoplasm unstimulated (Ac,u). This gives the value of SILAC 
ratios as the following:  
Sn = An,s / An,u 
Sc = Ac,s / Ac,u  
St = (An,s  + Ac,s) / (An,u + Ac,u)  
As results it has been found that the values of the nucleus fraction unstimulated fu and 
fraction stimulated fs are closely related to SILAC ratios as following: 
fu =An,u/ (An,u +Ac,u) = (St – Sc)/ (Sn – Sc), 
fs = An,s/ (An,s + Ac,s) = Sn (St –Sc)/ St (Sn –Sc). 
As results ratios for the distribution plan will be as following:  
Sn/St = fs/ fu and, Sc/ St = (1- fs) / (1- fu).  
The advantage of subcellular spatial razor formulation is that it can distinguish between 
changes in total protein abundance (St) and redistribution (Sn/Sc) to/from a target 
organelle (e.g. the nucleus). 
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Figure 1-9. Mathematical Formulation of the Spatial Razor Model. Letter (A) represent the 
correspondence appendance and letter (S) represent SILAC ratio H/L. The razor model 
postulated that proteins could be presented in the nucleus (n), cytoplasm (c), and total (t) 
fractions under stimulated (s) and unstimulated (u) conditions; when Sn is An,s/An,u, Sc is Ac,s/Ac,u 
and St is (An,s+Ac,s)/(An,u+Ac,u) (Pinto et al., 2014, Mulvey et al., 2013, Baqader et al., 2014).  
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1.5 Aim of Study  
 
The novel DNA replication origin activation checkpoint and its architecture has been 
recently described (Tudzarova et al., 2010) and the large scale shot gun quantitative 
proteomics study of Cdc7-depleted IMR90 fibroblasts (Mulvey et al., 2010, Mulvey et 
al., 2013) revealed that cells maintain reversible cellular arrest by initiating a dynamic 
quiescence-like response, and that the complexities of this phenotype will have 
important implications for the continuing development of promising Cdc7-targeted 
chemotherapeutics. This development is based on the fact that several cancer cells 
bypass G1/S arrest and progress to an abortive S phase triggering cell death. Targeting 
of Cdc7 with RNAi results in cancer cell specific killing in numerous tumours (Blow 
and Gillespie, 2008); but, at the same time may protect non transformed cells by 
reversibly arresting them in G1/S phase (Rodriguez-Acebes et al., 2010).  
Our quantitative large scale proteome analysis of Cdc7 depleted IMR90 fibroblasts 
revealed that an extensive range of biological changes such as altered cellular energy 
flux, mild oxidative stress response, lower proliferative capacity are spatially distributed 
over various subcellular locations inducing a dynamic quiescence-like response 
(Mulvey et al., 2010). 
The global and subcellular proteome analysis of Cdc7 depleted IMR90 fibroblasts 
generated considerable interest due to its implications for the development of promising 
Cdc7-targeted cancer therapies.   
In order to understand the mechanism of DNA origin activation checkpoint in normal 
human fibroblasts under oxidative stress we undertook the present study. The strategy 
to achieved the study aims are summarised in Figure 1-10. 
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The aims of this study are to: 
 
1. Investigate oxidative response of normal IMR90 fibroblasts by use of tert-butyl-
hydrogen peroxide TB-H2O2 and large-scale quantitative SILAC LC-MS/MS 
proteome analysis. 
2. Investigate and compare quantitative dynamical changes in nucleus and 
cytoplasm of IMR90 cells under oxidative stress. 
3. Evaluate proteome data sets of IMR90 fibroblasts under oxidative stress.  
4. Investigate resulting protein pathways involved in IMR90 response to oxidative 
stress. 
Following detailed bioinformatics analysis of identified pathways we hope to 
understand the cellular changes at G1/S arrest under oxidative stress. In addition, these 
results will provide the reference point for Cdc7 targeted drug development.  
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Figure 1-10. The Schematic of SILAC Experiment for the Use of Quantitative Proteomics 
to Study the IMR90 Human Fibroblast Cells under Mild Oxidative Stress. A combined 
strategy involving oxidative stress, protein subcellular fractionation, 1D SDS-PAGE, LC-
MS/MS data acquisition with LTQ-Orbitrap, and downstream bioinformatics for identification, 
quantification, statistical evaluation and network analysis was applied in this study. 
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Chapter 2: Materials and Methods 
 
2.1 Materials 
 
2.1.1 Chemicals and Reagents  
 
Most of the chemicals that were used in the preparing of buffers and washing solutions 
were purchased from SIGMA Aldrich Company Ltd, Poole, UK.  
Other purchases were obtained from different companies as following:  
 
• Martials for Cell Cultures: 
LGC Standards, Middlesex, UK: 
IMR-90 (#ATCC CCL-186), a human diploid fibroblast cell line from foetal lung 
tissue. 
Gibco, life technologies, Invitrogen, Manchester, UK: 
D-MEM (#31966-021), a Dulbecco's Modified Eagle Medium with high glucose, 
GlutaMAX™ and pyruvate. 
FBS (#26400-044), a dialyzed foetal bovine serum. 
Thermo Scientific, Rockford, USA: 
SILAC kit (#89983), stable isotope labeling by amino acids in cell culture 
(SILAC).  
The kit contains:  
D-MEM, heavy 13C6- (Lys6), light L-Lysine (Lys0) and dialyzed FBS. 
The Heavy 13C6 15N4-L- Arginine (Arg10) (#89990) was purchased separately 
from the same provider. 
Sigma, Gillingham, UK: 
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Trypsin-EDTA (#T4049).  
DMSO (#472301), dimethyl sulfoxide. 
SIGMA Aldrich Company Ltd, Poole, UK: 
TB-H2O2 70% wt. (#458139), tert-butyl- hydrogen peroxide (TBP).  
TEMED (#T9281), tetra-methylethylenediamine.  
APS (#A3678), Ammonium pre-sulfate.  
 
• Martials for Proteomics Laboratory: 
Bio-rad, Hemel Hempstead, UK 
Bio-Rad protein assay (#500-0006).  
Merck Millipore, Darmstadt, Germany 
Acetone (#100020.100).  
National Diagnostics; Hessle, Yorkshire, UK 
The ultra pure acrylamide proto-Gel 30% (w/v) arcylamide: 0.8% (w/v) Bis acryl-
amid stock (37.5:1) (#EC-890). 
Millipore Corporation, Billerica, MA: 
β–galactoaidase senescence kit (KAA002).  
• For mass spectrometry: 
ARISTAR, VWR international, UK: 
Formic acid.  
Merck, Darmstadt, Germany: 
Acetonitrile (MS grad).  
• Martials and Antibodies for Western Blotting: 
Abcam, Cambridge, UK: 
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 Catalase (#ab76110); Superoxide Dismutase 1 (#ab79390); Glutathione 
Peroxidase 1(#ab108429), Nrf2 (ab89443), Keap1 (ab66620) and β-Actin 
(#ab75186). 
 The Secondary antibodie (#ab 97245), Anti-goat for anti-mouse IgG2a HRP-
linked Antibody. 
Cell Signalling, New England Bio-lab, Hitchin, Hertfordshire, UK: 
Anti-Cdc7 (#3603S). 
Secondary anti-rabbit IgG HRP-linked Antibody (#7074S). 
Merck Millipore, Darmstadt, Germany:  
Anti-p53 (#Merck Ab-6-100).  
GE health care life science, Buckinghamshire, UK: 
Western Blotting Detection kit Amersham ECL Plus (#RPN2132). 
Bio-Rad, Hertfordshire, UK: 
Kaleidoscope Standards (#161-0375), Precision plus Protein with detection range 
from 10-250kD.  
GE Healthcare limited, Buckinghamshire, UK: 
Whatman Nitrocellulose Transfer Membrane (#10401396 & lot: D146795). 
WB films Amersham HyperFilm ECL (#28906837). 
Whatman Gel Blotting paper (#10426994 & lot: D109105).  
SIGMA Aldrich Company Ltd, Poole, UK: 
Sliver stain kit (#PROTSIL1). 
Promega, Southampton, UK: 
Trypsin Gold for mass spectrometry (#V528A).  
Roche Products Limited, Welwyn, UK:  
Roche completes protease inhibitor cocktail tablets (#11836145001). 
Phospho-stop (#04906845001). 
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• For Immune-Cyto-Chemistry:  
Thermo Fisher Scientific Inc; Rockford, USA: 
Anti-ATP5A1 antibody produced in rabbit (#PA5-27504).  
Atlas antibodies, Sigma, Gillingham, UK: 
Anti-ALDH18A1 antibody produced in rabbit (#HPA008333).  
Sigma, Gillingham, UK: 
Anti-Rabbit IgG (whole molecule)–FITC antibody produced in goat (#F0382). 
Formaldehyde for molecular biology 36.5% (#F8775). 
Triton X-100 (#033K0605). 
Molecular Probes-life technologies, Invitrogen, Manchester, UK: 
Mitotracker Green FM (#M-7514).  
Mitotraker Deep reed FM (#M22426).  
Hoechst 33342- readymade (#R37605). 
VECTOR LABORATORIES LTD, Peterborough, UK: 
VECTASHIELD Mounting Medium (#H-1000). 
 VECTASHIELD with DAPI (#H-1200). 
SIGMA Aldrich Company Ltd, Poole, UK: 
Glycerol (#G6279). 
• For FACS Analysis:  
SIGMA Aldrich Company Ltd, Poole, UK: 
Propidium Iodide (PI) dye (#P4864). 
Ribonuclease A from bovine pancreas (#R4875).  
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2.1.2 Equipment and Software 
 
SIGMA Aldrich Company Ltd, Poole, UK: 
Siliconized micro-centrifuge tubes (#T3406-250EA). 
NUNC-immuno-flat bottom plates (#M9410). 
Corning, NY, USA; Cell star, Greiner Bio-One Ltd; UK and Falcon BD, 
Erembodegem, Belgium: 
175, 75 and 25cm2 flasks. 
BD biosciences discovery lab ware, Bedford, USA: 
8 and 4 wells BD Falcon culture slides (#354108; 354104). 
Willcowells, Amsterdam, Netherland: 
Glass bottom culture dishes with deiameter12 mm and glass thickness 1.5 
(#GWSt-3512). 
Total laboratory services, Dorset, UK: 
Eppendrof centrifuge (#5804R).  
Biofuge, Heraeus instrument, Kendro laboratory products, Germany: 
Bench-top micro centrifuge. 
MSE, London, UK: 
Sonicator Soniprop150. 
Millipore, Consett, Durham, UK: 
Water purification system MilliQ for distilled and deionized the water with a 
Quantum EX (Organex Resin) cartridge.  
Millex-GS Filter Unit (#SLGS033SB). 
Digilab, Genomics Solutions, Huntingdon, UK: 
ProGest Investigator, blue and red 96 well Microtiter plates tht used for alkaline-
reduction process (#PRO10005, 10004 and 10006).  
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Qmax Lab., Chaomcol, Welwyn Garden city, Hertz, UK: 
Chromatography vials (#V1504) with a black cap (#V0698).  
Laboking, Paris, French: 
2ml Cryotube, Ext-Thread (#COR-CT-01).  
Bio-Rad, Herts, UK: 
Mini-Protean III electrophoresis cell system tanks, 1.0mm glass plates, semidry 
electroblotting and electrophoresis power supplier.  
GE health care life science, Buckinghamshire, UK: 
Hyper film ECL (#28-9068-35), film cast and Whatman’s nitrocellulose blotting 
membrane (#Protran BA85). 
Beckman Coulter Inc., Orange County, CA: 
Flow cytometer DAKO/Beckman Coulter MoFlo High speed sorter.  
Speedvac plus SC110A, Savent, instrument Inc., Holbrook: 
Vacuum evaporator centrifuge.  
Anthos htll, Slazburg: 
Standard spectrophotometer for calorimetric assays. 
Olympus KeyMed Ltd., Essex, UK: 
Olympous-CK2 inverted light microscope, attached to Axio Cam MRM ZEISS 
camera and the picture visualizer software Axio-Vision released at 4.5 SP 
(3/2006).  
PerkinElmer, Cambridge, UK: 
Perkin Elmer spinning-disk confocal laser microscope.  
Thermo Fisher Scientific, Fremont, Canada: 
LTQ-Orbitrap Classic mass spectrometer (XL), Surveyor MS pump and liquid 
chromatography Micro AS auto sampler.  
Reprosil, Nikkyo Technos CO, Tokyo, Japan: 
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MiChrom C18 cap trap for desalting and nanoelectrospray ion source that 
consisted of a fused silica capillary column (i.d. 100 µm; o.d.360 µm; length 20 
cm; 5 µm C18).  
Matrix Science, London, UK: 
Protein and peptide identification software tools, Mascot software (version 2.2). 
Max Planck Institute of Biochemistry, Martinsried, Germany: 
The quantitation software for SILAC labeling quantitation, MaxQuant coupled 
with Andromeda Configuration (versions 1.3.0.5); and Perseus (versions 1.3.0.4) 
were downloaded from http://maxquant.org/faq.htm; and from MaxQuant help  
http://groups.google.com/group/maxquant-list	  	  
Uniprot website (http://www.uniprot.org): 
Human fasta file:  
(ftp://ftp.uniprot.org/pub/databases/uniprot/current_release/knowledgebase/proteo
mes/) accessed and download at 31-10-2012. 
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2.1.3 Buffers and Stock Solutions 
 
10X TBS buffer 
500mM Tris-Cl pH 7.5 and 1.5M NaCl in 1L of distilled H2O.  
TBST buffer 
1X TBS with 0.2% Tween 
10X PBS buffer 
1.37M NaCl, 27mM KCl, 100mM Na2HPO4 and 18mM KH2PO4 in 1L of H2O. 
PBS+ buffer 
1X PBS, 1mM CaCl2 and 0.5mM MgCl2. 
Fractionation buffer 
Buffer A: 10mM HEPES pH 7.9, 10mM KCl, 0.1% Triton X-100, 2mM EDTA, 2mM 
DTT, 0.34M sucrose and complete protease inhibitor cocktail tablets. 
Buffer B (Isotonic sucrose IS buffer): 100mM NaCl and 200mM sucrose. 
RIPA buffer 
50mM Tris-HCl pH 7.4, 300mM NaCl, 1% sodium deoxycholate, 1% NP-40, 1mM 
EDTA, 0.1% SDS. 
2X Sample buffer  
4% of 10% (w/v) SDS, 2% Glycerol, 120mM of 1M Tris-HCl (pH 6.8) and 0.02% of 
bromophenol blue dissolved in distilled H2O.  
Transfer buffer 
48mM Tris-HCl, 39mM Glysine and 20% methanol dissolved in distilled water. 
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2.2 Methods 
 
2.2.1 Methods used in Cell Culture Laboratory  
2.2.1.1 Cell Culture and Growth Conditions and SILAC Labeling 
 
IMR-90, a human primary diploid fibroblast adherent cell line was obtained from the 
provider at population doubling (PD) 12, and was cultured with PD of less than 22 
and tested for senescence by the measure of β–galactosaidase activity within the 
cells. Cells were cultured under normal growth conditions 37 ºC and 5% CO2 in D-
MEM medium that contained high glucose, Glutamax and pyruvate plus 10% FBS.   
Cells were initially plated at T25 flask with capacity 500,000 cells per flask and 
incubated from overnight to three days. After cells recovered, they were washed with 
37oC warmed up PBS p.H 7.4, detached from surface by the use of trypsin-EDTA 
and moved to T75 flasks that contained SILAC-DMEM media supplemented with 
10% of SILAC dialyzed foetal bovine serum FBS. The SILAC medium was prepared 
by following the manufacturer’s instructions (Thermo Scientific, UK).  
For SILAC quantitative analysis, cells were divided into two populations and were 
cultured in either light medium containing amino acids 12C6, 14N4-Arginine and 12C6-
lysine (Arg0, Lys0) or heavy medium containing amino acids 13C6, 15N4-Arginine 
(Arg10) and 13C6-lysine (Lys6) by at least 7 passages in parallel in order to achieve a 
full incorporation of SILAC amino acids. The full incorporation of heavy isotope 
was checked by mass spectrometry of samples of heavy/or light lysed cells (Mulvey 
et al., 2010, Mulvey et al., 2013, Ong and Mann, 2006). 
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2.2.1.2 Cell Counting  
 
Small amount of the suspended cells in growth medium were mixed gently with 
trypan blue in ratio (1:1) by the use of serological pipette in cleaned Eppendrof tube. 
The mixture was drawn out gently to the edge of the chamber of a cleaned 
haemocytometer with 70% ethanol and affixed with coverslip. Suspension was 
diffuse into the chamber groove by capillary actions. The hemacytometer was 
viewed under the light microscope by the use of the 10x objective lens, and the cell 
numbers were counted only inside the four corners that consisted of 16 square and 
the central square of the slide manually.  
Calculations normally done to determine the total number of cells per ml by applying 
the following equation: 
Total cells /ml= total cells counted x (#dilution factor / #number of squares) x 104  
Total cell numbers in the flask= Total cells/ml x Total sample volume in the flask 
For cells viability= (Live cell count (shiny rounded cells)/ Total cell numbers) x 100  
 
2.2.1.3 Preparation of Cryoprotective Medium for Storing of the IMR90 cells and 
Thawing Process  
 
The harvested cells were spun down at 125g for 5 minutes combined with 2x wash 
with PBS to remove the excessive amount of the old medium. Cells were re-
suspended in a fresh complete growth medium that was supplemented with 10% 
(v/v) DMSO at room temperature. The re-suspended cells were transferred into 
cryotube and kept at -80oC overnight then transferred to liquid nitrogen for long term 
storing.  
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For thawing the cells, the cryotube was taken form liquid nitrogen and placed 
immediately at 37oC water path; sprayed with 70% ethanol. The sample was diluted 
with 10ml of fresh and 37oC in a warmed DMEM and spun down at 125g for 10 
minutes to prevent toxicity of DEMSO on the cells. Old medium was discarded and 
cells were re-suspended in new fresh DMEM medium.  
 
2.2.3 Cell Treatment 
2.2.3.1 Oxidative Stress 
 
Mild oxidative stress was exerted upon IMR90 cells according to a published 
protocol (Tudzarova et al., 2010, Chen et al., 2004) with minor modifications. Heavy 
cells were treated with 50µM tert-butyl hydrogen peroxide TBP in cell culture media 
for 2h, while the light cells were treated with 50µM PBS and used as control. The 
treatment was stopped by replacing the cell culture medium with fresh medium 
without peroxide. On the next day, the heavy cells were again treated with TBP for 
1h. Four hours after the removal of media containing peroxide, heavy or light cells 
were detached from the surface of tissue culture flasks by use of Trypsin-EDTA, 
washed three times with PBS p.H 7.4 and recovered by centrifugation at 60g. For 
sample preparation, a total of 4 flasks each of heavy and light cells were used.  
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2.3 Methods used in Proteomics Laboratory  
2.3.1 Sample Preparation 
 
Protein concentration was measured by the use of the Bio-Rad protein assay kit. 
Heavy and light cells were mixed in a 1:1 ratio based on protein concentrations and 
the amount of cell pellet (Ong and Mann, 2006, Walther and Mann, 2010). Cell lysis 
and subcellular fractionation were performed in order to obtain cytoplasmic (C, 
nuclear-depleted fraction) and nuclear fractions (N). Cells were lysed as described in 
Mulvey et al. (Mulvey et al., 2010) in hypotonic buffer A. After 10 minutes of lysis, 
the salt concentration and viscosity of the buffer was adjusted by addition of (isotonic 
sucrose buffer B; IS buffer). Following a 5 minutes centrifugation at 2000g, the 
supernatant was collected as the crude cytoplasmic fraction. The nuclear fraction in 
the pellet was washed twice in IS buffer by an additional two centrifugation steps for 5 
minutes at 2000g, with the washings restored to the crude cytoplasmic fraction. The 
crude cytoplasmic (nucleus-depleted) fraction was cleared by centrifugation at 13000g 
for 15 minutes and the supernatant used as the cytoplasmic fraction.  
The cytoplasmic fraction was concentrated using the Aston precipitation method by 
adding 4:1 volumes of chilled acetone to the sample, which was kept overnight at -20 
ºC. On the next day the sample was centrifuged and washed three times with chilled 
acetone at 13 000g for 10 minutes at 4 ºC. The pellet was air dried for 5 minutes at 
room temperature to eliminate any acetone residue and then dissolved in modified 
RIPA buffer.  
 
2.3.2 Protein Separations and In-Gel Digestion 
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For each of the nuclear (N) and cytoplasmic (C) samples 60µg of total protein was 
separately resolved by 10% SDS-PAGE under reducing conditions. Proteins were 
visualized by silver staining with ProteoSilver Plus kit (Shevchenko et al., 1996). At 
least 30 horizontal bands were excised from each gel lane and processed on a 96-well 
Progest plate. Gel bands were processed with the Progest Investigator using 
established protocols for reduction and alkylation (Shevchenko et al., 2006). Finally, 
gel plugs were rehydrated in 20µg/ml sequencing grade modified trypsin (trypsin-
Gold) that was prepared by adding (1:50 v/v) trypsin/25mM ammonium bicarbonate, 
and incubated overnight at 37 °C. Fifty microliters of 0.1% formic acid was added in 
order to stop the tryptic digestion, the extracted tryptic peptides were collected in 
siliconized Eppendorf tubes and vacuum-dried to about 20µl, the volume adjusted to 
approximately 30µl with 0.1% formic acid, and the sample analysed by Orbitap LC-
MS/MS. 
 
2.4 Immunoblotting 
 
Treated heavy (T) or untreated light cells (UT) were lysed in SDS-sample buffer for 3 
minutes at 90 ˚C and 60µg protein/lane resolved by 10-12% SDS-PAGE under reducing 
conditions. Proteins were transferred from gels onto Nitrocellulose membranes by semi-
dry electroblotting (15 V for 1hr). For oxidative stress markers, the membrane was 
blocked with 5% semi–fat milk powder TBS-tween20 for 1hr followed by 3X washing 
with TBST; the antibodies were blocked in 5% semi–fat milk powder TBS-tween20 
over night at 4 ˚C. The antibody concentrations were: 1:10000 of superoxide dismutase 
1 (SOD1), 1:1000 of Glutathione peroxidase 1 (GPX1) and 1:500 of catalase. For the 
proteins Cdc7, p53, Nrf2 and Keap 1, the membrane was blocked with 10% semi–fat 
milk powder PBS for 1hr or overnight at 4 ˚C followed by 3X washing with PBS prior 
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to the use of the antibodies. The antibody concentrations were: 1:1000 Cdc7, 1:1000 
p53, 1:300 Nrf2 and 1:500 Keap 1. 
The next day the membranes were washed 3-5 times either with TBS-tween20 or PBS 
for 10 minutes each and incubated for an hour and half at RT with the appropriate 
secondary antibodies dissolved in 5% semi-fat milk powder TBS-tween20 or 10% 
semi–fat milk powder PBS. Secondary antibody concentrations were 1:2000 anti-rabbit 
IgG HRP-linked Antibody and 1:2500 Goat for anti-mouse IgG2a HRP-linked 
Antibody. Finally, the membranes were washed as described above. However, the last 
washing step for TBS was without tween20 to avoid interference with the ECL 
detection reagent. WB bands were visualised using ECL developing reagents kit by 
following of the manufacturer’s instructions (GE healthcare, Buckinghamshire, UK).  
 
2.5 Cell Cycle Analysis 
 
Flow cytometery or FACS for cell cycle analysis followed the procedure described by 
Tudzarova et al., 2010 (Tudzarova et al., 2010). Heavy and light cells were collected 
and fixed overnight at -20 ºC in 80% methanol in PBS. Cells were precipitated by 
centrifugation at 50g for 10 minutes, the supernatant was discarded and the cells 
suspended in a Propidium Iodide master mix in PBS containing 50µg/ml RNase A, 
50µg/ml Propidium iodide solution and protease inhibitors with a final cell density 
of 1x106 cells/ml. Cells were incubated at 37 ºC for 30 minutes in darkness. Cells were 
sorted by use of a DAKO/Beckman Coulter MoFlo High speed sorter. The forward 
scatter signal was used for detection of cells and the propidium iodide signal 
fluorescence was linearly quantified to rationalize DNA content after excitation at 488 
nm in the orange/red channel (613/20 nm band-pass filter) (Tudzarova et al., 2010). 
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2.6 Immunofluorescence and Confocal Microscopy 
 
To validate that nuclei and mitochondria remained structurally intact before and after 
oxidative stress, immunofluorescence and confocal microscopy were used. The IMR90 
cells were grown in glass bottom Petri dishes 12 mm, 1.5 thicknesses. Control and 
TBP-treated IMR90 cells were washed three times with PBS+. Mitochondria were 
stained with 100nM of MitoTracker green M-7514 in the cell culture growth medium 
for 30 minutes at 37 ºC, followed by two washes for 5 minutes with medium at normal 
growth condition. The nuclear staining was performed by adding 1.5 drops of Hoechst-
readymade to the medium for 15 minutes in the dark at room temperature.  
Alternatively, prior to imunocytochemistry, cells were stained with 200nM MitoTracker 
deep red FM as before, directly fixed and permeablized for 5 minutes at -20oC with ice-
cold 1:1 methanol-acetone; and washed 3X with PBS for 2-5 minutes each. Primary 
antibodies for ALDH18A1 and ATP5A1 were respectively diluted 1:50 and 1:25 in 4% 
PBS/FBS and incubated with the fixed cells at 4 ºC overnight. Cells were subsequently 
washed 4X for 10 minutes with PBS and incubated for an hour and half in the dark with 
1:1000 fluorescent secondary FITC antibody diluted in 4% FBS/PBS. Nuclei were 
stained and cells were covered with VECTASHIELD mounting media with DAPI. 
Image acquisition was performed with a Perkin Elmer spinning-disk confocal laser 
microscope and a 63×/1.4 numerical aperture oil immersion lens. The excitation 
maximum (nm) and emission maximum (nm) was the following: for DAPI, 358 and 
461; for Hoechst 3342, 352 and 461; for Mitotracker Green FM, 490 and 516; for 
Mitotracker Deep red FM, 644 and 665; for FITC, 490 and 525 respectively. 3D images 
were taken with help from Mr. Thomas Adejumo from the Wolfson Institute for 
Biomedical Research and the UCL Cancer Institute (UCL, London, UK). 
 
	   82 
2.7 Mass Spectrometry 
 
LC-MS/MS analysis was performed on a classic LTQ-Orbitrap equipped with a 
SURVEYOR-MS pump and Thermo Micro AS-autosampler. Peptides were resolved or 
loaded using a fused silica capillary column, which is a part of the nanoelectrospray ion 
source with an initial desalting step using a MiChrom C18 Captrap for peptides. Liquid 
chromatography was carried out at ambient temperature at a flow rate of 500nl/min 
using a dual gradient of Buffer A: 0.1% formic acid and Buffer B: 100% acetonitrile 
(ACN) with 0.1% formic acid. Separation was achieved by a 5-23% buffer B gradient 
(95-77% Buffer A) for 65 minutes, followed by 23-40% Buffer B (77- 60% Buffer A) 
gradient for 30 minutes, and a step gradient to 60% Buffer B for 5 minutes. Full Profile 
data was acquired on the LTQ-Orbitrap. 
The measurements were done under positive ion mode. The tuning parameters were as 
follows: spray voltage 1.40kV, capillary temperature of 200°C. A full scan was 
collected for eluted peptides in the range 450-1600 m/z with the Orbitrap portion of the 
instrument at a resolution of 60,000 followed by MS/MS using CID (Collision Induced 
Dissociation) with dynamic exclusion of 40s and a maximum number in the dynamic 
exclusion list of 500 in the LTQ portion of the instrument with a minimum count 
threshold of 500. An activation q value of 0.25 and activation time of 30ms was applied 
for MS2 acquisitions. X!Calibur software version 2.0.7 was used for data acquisition as 
in Mulvey et al., 2010. Homo sapiens species restriction with the number of protein 
entries searched: 218,357. 
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2.8 Data Analysis, Protein Identification and Quantification 
 
Raw MS files from all replicate SILAC experiments were uploaded into the MaxQuant 
software platform (version 1.3.0.3) for peak list generation, quantification of SILAC 
pairs, identification of individual peptides, protein identification and assembly into 
protein groups. XCalibur raw files were processed and searched against a UniProt fasta 
file. Selected MaxQuant analysis parameters included trypsin enzyme specificity, 
SILAC doublet measurements of Lys6 and Arg10, 2 missed cleavages, minimum 
peptide length of 7 amino acids, minimum of 2 peptides (1 of which is unique), top 6 
MS/MS peaks per 100 Da, peptide mass tolerance of 10 ppm for precursor ions, and 
MS/MS tolerance of 0.5 Da. Oxidation of methionine and N-terminal protein 
acetylation were selected as variable modifications, and cysteine carbamidomethylation 
was selected as a fixed modification. All proteins were filtered according to a false 
discovery rate (FDR) of 1% applied at both peptide and protein levels. Proteins were 
automatically quantified by the MaxQuant software: a minimum of 2 peptide ratio 
counts from razor and unique peptides were necessary for protein quantification, and the 
“requantification” option was enabled. An Experimental Design template was used to 
specify individual experiments and reverse labeling conditions within the analysis. The 
final Protein Groups and peptide text files were processed with Perseus (versions 
1.3.0.4). Peptides with a normalized Significance B score of p < 0.05 were included for 
downstream analysis (Cox and Mann, 2008, Cox et al., 2009, Mulvey et al., 2010)  
 
2.9 Correlation of Proteins across Different Samples  
 
The MaxQuant software package (Cox and Mann, 2008, Cox et al., 2009) was used to 
identify proteins for 12 data analysis sets: (a) each nucleus (N) sample replicate and the 
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union of the three N samples, (b) each cytoplasm (C) sample replicate and the union of 
the three C samples, (c) each C&N replicate and the union of the three C&N samples. 
C&N denotes that for each individual biological replicate, the MS data for the C and N 
samples were jointly processed with MaxQuant to estimate changes in total protein 
abundance. For this data, a correction for enrichment of nuclear proteins in the MS data 
analyses was applied during estimation of total protein abundance. Across these 
samples, a total of 4429 protein sequence groups were found. For the same underlying 
gene, slightly different protein sequence groups were sometimes observed depending on 
the exact set of peptides detected in each sample. Using the principle that sequence 
groups in different samples that correspond to the same underlying protein(s) must have 
protein sequences in common, the union of the unique peptides for protein sequence 
groups with shared protein sequences was formed and used to re-query the full UniProt 
human sequence data set to identify “consensus” sequence groups across the three 
sample types. This gave 3589 independent proteins (sequence groups) for which the MS 
data, including the individual replicates, is given in Supplementary Table 1.external CD 
All of the consensus sequence groups contained at least one consensus protein sequence 
that contained all unique peptides in the group and all were independent, i.e. there were 
no protein sequences shared between different consensus protein sequence groups 
(Pinto et al., 2014, Mulvey et al., 2013, Baqader et al., 2014).  
 
2.10 Selection of Significantly Changed Proteins  
 
To select a set of proteins showing the most significant changes in SILAC ratios for the 
oxidative stress experiments we used the MaxQuant Significance B score (Cox and 
Mann, 2008) (SigB hereafter) and procedures analogous to those applied previously for 
cell cycle arrest (Mulvey et al., 2010, Mulvey et al., 2013). A minimum of at least 3 
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ratio counts were required for inclusion of a SILAC ratio in the selection procedures. 
For SILAC ratios measuring changes in the nuclear (Sn), cytoplasmic (Sc) and total (St) 
abundances, we used the cutoff limits SigBunion < 0.002 and SigBreplicate < 0.006, where 
SigBunion refers to the union over the three replicates (e.g. the 3 nuclear replicates) and 
SigBreplicate refers to the individual replicates (e.g. each nuclear replicate). Proteins 
showing the most significant changes in Sn, Sc and St were selected with the joint 
requirement SigBunion < 0.002 and SigBreplicate < 0.006 for at least two replicates. For the 
redistribution parameter Sn/Sc, which detects nucleus-cytoplasmic redistribution even in 
the absence of changes in total protein abundance (Mulvey et al., 2013, Pinto et al., 
2014), we used the joint limits |log2(Sn/Sc)|union > 0.9 (0.54 > Sn/Sc > 1.87) and 
|log2(Sn/Sc)|replicate > 0.8 for at least two replicates. This led to selection of 121 proteins 
(the 121-OxS set, see text) for subsequent network analyses. A summary for these 
proteins and the selection procedures is given in Supplementary Table 2, external CD. 
As described previously,(Mulvey et al., 2013) the concomitant use of limits on the 
union and on individual replicates tended to select proteins with substantial numbers of 
ratio counts, i.e., a minimum of 9 ratio counts (in a single sample) and a median of 120 
ratio counts per protein were used in classifying the proteins in the 121-OxS set 
(Mulvey et al., 2013, Pinto et al., 2014, Baqader et al., 2014).  
 
2.11 Bioinformatics Analysis of Functional Networks 
 
For the identification of functional annotations, associations, interactions and networks 
within the dataset, combinations of several data analysis tools were used. The consensus 
Gene Name identifiers for the 121-OxS set of most significantly changed proteins were 
uploaded into STRING version 9.1 (Search Tool for the Retrieval of Interacting 
Genes/Proteins), to create a protein interaction network based on known and predicted 
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protein-protein interactions (Franceschini et al., 2013, Szklarczyk et al., 2011). A 
threshold confidence score of 0.7 was used to ensure that only highly confident protein 
interactions were considered for inclusion in the network. Seven types of protein 
interaction information were used for network generation, including neighbourhood, 
gene fusion, co-occurrence, co-expression, experimental, database knowledge and text 
mining. Three networks from STRING were further analysed: the 121-OxS set, a 240-
OxS set containing an additional 119 “white nodes” densely connected to 121-OxS that 
were suggested by STRING, and a 180-OxS set containing the 121-OxS set and 59 of 
the 119 “white nodes” quantified in our experiments, but not amongst the proteins 
showing the most significant changes (see text). Densely connected clusters in these 
networks were identified with MCODE 1.32. (Bader and Hogue, 2003) BiNGO 2.44 
(Maere et al., 2005) was used to obtain enriched GO BP (biological process) terms. 
DAVID (Huang da et al., 2008) was used to scan for other types of annotations. The 
combined STRING, BINGO and DAVID results were used to select a set of 32 GO 
biological process terms to describe the cellular response (Table 3-2). These terms 
corresponded to groups of proteins with enriched GO BP terms, but we also included 
additional terns to cover other proteins selected as significant in the 121-OxS set. The 
networks were imported into Cytoscape version 2.8.2 for further analysis and 
visualisation (Shannon et al., 2003, Smoot et al., 2011). Other groups of proteins, e.g., 
proteins annotated to glycolysis (see text), were selected for comparison using the 
QuickGO (Binns et al., 2009) facility at the European Bioinformatics Institute 
(http://www.ebi.ac.uk/QuickGO/) with appropriate sets of GO identifiers. 
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Chapter 3: Results: Nuclear-Cytoplasmic Trafficking of 
Proteins is a Major Response of Human Fibroblasts to 
Oxidative Stress1 
	  
3.1 Introduction 
  
The cellular oxidative state has been known to contribute to different disease processes. 
Recently there has been huge interest in the roles of ROS and mitochondria in diseases 
such as diabetes, inflammatory diseases, neurodegenerative disease such as Parkinson’s 
and Alzheimer diseases and also cancer (Brownlee, 2001, Finkel et al., 2007, Lin and 
Beal, 2006, Nathan, 2002, Naik and Dixit, 2011).  
As there is interest in the protein damage caused by ROS, one of the active research 
branches is currently aimed at understanding the processes responsible for the protein 
damage and biological quality control process such as mitophagy and autophagy (Ryter 
and Choi, 2013, Lee et al., 2012). As a result, this led to the finding that, under specific 
physiological conditions, ROS tend to act as strong signaling systems (Droge, 2002, 
Ray et al., 2012). The intimate participation of ROS on the mitochondrial oxidative 
environment, where mitochondria are the origin of most of the ROS production and 
most mitochondrial proteins depend on ROS response (Park et al., 2011), recently 
became more attractive, especially for cysteine-related protein systems (Mailloux et al., 
2013). However, ROS can also be generated by other processes in other locations such 
as by the NOX family of enzymes (Gough and Cotter, 2011, Babior et al., 2002, Chen 
et al., 2008, Block and Gorin, 2012, Bedard and Krause, 2007) and the roles of ROS 
signaling may be exclusive to certain cellular locations. The redox spatial localisation 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  The	  results	  of	  this	  chapter	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  on	  the	  journal	  of	  proteome	  research	  (on	  18-­‐08-­‐2014)	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   the	   same	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   Authors’	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   to	   that	   scientific	   paper	  was	   as	   following;	   KS,	  MR	  and	   JGZ	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  the	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  MR,	  KS	  and	   JGZ	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  the	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  NB,	  MC	  and	  MR	  performed	  the	  
experiments;	  NB	  did	  the	  Maxquant	  analysis	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  the	  obtained	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  checked	  by	  JGZ;	  
JGZ	  and	  MR	  wrote	  the	  scientific	  paper	  manuscript.	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within the eukaryotic cellular compartments may participate in the control of ROS-
related signaling (Go and Jones, 2008, Hansen et al., 2006).  
The proteome of cellular organelles and their subcellular protein distribution are highly 
dynamic and affected by different conditions (Henke et al., 2011, Jung et al., 2013, 
Mulvey et al., 2013, Pinto et al., 2014, Qattan et al., 2012). Therefore, it is not 
surprising that the response of cells to ROS and oxidative stress may also influence the 
dynamics of the cell proteome. For example, under oxidative stress and ROS signaling, 
the Nrf2 protein becomes detached from the cytoplasmic-associated protein Keap1 and 
translocates to the nucleus to interact with the antioxidant response element (ARE) in 
the presence of phosphorylation signals and lipid peroxidation proteins (McMahon et 
al., 2003, McMahon et al., 2010, Zhu et al., 2008, Numazawa et al., 2003, Lee et al., 
2014, Itoh et al., 1997). Nrf2 usually regulates antioxidants to control ROS levels, and 
Nrf2 activation depends on the oxidation state of cysteine residues (Kaspar et al., 2009, 
Bloom et al., 2002, Zhang and Hannink, 2003).  
The need for a global, spatially-resolved monitoring system to address the changes in 
functional protein processes between various subcellular locations might help to 
understand cellular responses to specific conditions such as stress simulations caused by 
the use of mild tert-butyl peroxide (TBP) treatment. Thus, it was postulated that protein 
trafficking between subcellular compartments might be sensitive to oxidative stress.  
 
3.2 Results 
 
In this study, the intracellular protein translocation/abundance oxidative stress response 
of human diploid fibroblast IMR90 cells has been analysed by using high-throughput 
proteomics subcellular spatial razor experiments (Mulvey et al., 2013, Pinto et al., 
2014).  
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The experimental workflow is outlined in Figure 1-10. Three data sets with their 
replicates were obtained: (1) nucleus-enriched protein sample (N), (2) the nucleus-
depleted (cytoplasm) sample (C), and (3) a total protein sample (T). The corresponding 
SILAC ratios (H/L) were afforded measures for each protein of the general change in 
total (St), or of the localised change in protein abundance in the nucleus (Sn) or 
cytoplasm (Sc).  
  
3.2.1 The Cellular Response to the Treatment  
 
The TBP amount was optimised by applying increasing concentrations of TBP to 
IMR90 cells. Microscopic pictures show the response of IMR90 cells to different 
concentrations of TBP: 0, 12, 25, 50, 100 and 200µM (Figure 3-1). The highest dose 
of 200µM of TBP appeared to reduce the cell number compared to the control. The 
lowest dose of 12µM of TBP showed no effect on the number of cells. Concentrations 
between 50µM and 100µM did not show a severe reduction in cell numbers compared 
with high dosages, or the cell numbers were not changed to the levels seen in low 
dosages. 
Analysis of cell distribution in different phases of the cell cycle revealed that at 50µM, 
75µM and 100µM of TBP, oxidative stress caused arrest and accumulation of IMR90 
cells in both G1 phase (57, 42 and 49%), G2/M phase (37, 53 and 44%) and very 
small S phase peak (6, 5 and 7%), respectively, with no sub-G1 peak for the dead cells 
compared to the control (Figure 3-2).  
 
3.2.2 Western Blotting for the Oxidative Stress Associated Proteins  
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The TBP effect was also checked by the use of western blotting techniques. Antibodies 
for antioxidant proteins SOD1, GPX1, catalase, tumour suppressor protein p53 and cell 
division cycle 7 protein Cdc7 were tested. The WB showed that there was a change in 
all of these proteins compared to the control (Figure 3-3A).  
Fractionating the cells into nuclear and cytoplasmic fractions, and applying WB for the 
antibodies Nrf2 and Keap1 with each fraction, showed that Nrf2 appeared to translocate 
from the cytoplasm to the nucleus and was firmly presented on the nuclear fraction 
under oxidative stress; in contrast, the inhibitor Keap1 appeared pale and degraded in 
the treated cytoplasmic fraction compared to the control (Figure 3-3B).  
To obtain nuclear and cytoplasmic fractions, different nuclear fractionation buffers were 
used. The subcellular fractionation protocol was optimised by the use of the previously 
identified nuclear marker ‘Lamin A/C’ and the cytosolic marker ‘Tubulin’; the 
fractionations for each sample were tested for nuclear leakage by the use of MS (for 
results see Appendix 1 in attached CD).  
The protocol which showed the best organelle separation was chosen for the final 
experiment, that is, the one which gave the minimal amount of Lamin in the IMR90 
cytosolic fraction and the minimal amount of Tubulin in the nuclear fraction. In the 
fractionation samples used for the study, the recorded cytoplasm/nucleus MS intensity 
ratio for Lamin A/C fluctuated between 0.2 and 0.8% for the three replicates; that is, for 
IMR90 cells, there was negligible nuclear leakage during the fractionation process and 
this did not significantly affect the measured SILAC ratios (1.185 ≤ Sn ≤ 1.197, 0.964 ≤ 
Sc ≤ 1.009 for Lamin A/C over the three replicates). 
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Figure 3-1. IMR90 Cells with Different Dosages of TBP. Numbers of IMR90 cells appeared to vary 
under the light microscope after using different concentrations of TBP: 0µM, 12µM, 25µM, 50µM, 
100µM and 200µM.	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25µM/25µM TBP 
50µM/50µM TBP 
100µM/1000µM TBP 
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3. 
4. 
5. 
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Figure 3-2. FACS Analysis for the Distribution of IMR90 Cells over the Cell Cycle Phases. The cell 
cycle analysis of the nominated concentrations 50µM, 75µM and 100µM showed accumulation of the 
cells in the G1 phase (57, 42 and 49%) and G2/M phase (37, 53 and 44%), respectively, with very small S 
phase peaks (6, 5 and 7%) compared to the control and no sub-G1 peaks at all.  
 
 
 
 
 
 
Un-Treated Oxidative stress 
CO IMR-90 
G1     - 65% 
S        - 21% 
G2/M - 14% 
CO IMR-90 
G1     - 64% 
S        - 15% 
G2/M -  21% 
CO IMR-90 
G1     - 68% 
S        - 15% 
G2/M - 17% 
50/50 µM 
TBP 
G1     - 57% 
S        -  6% 
G2/M-37% 
100/100µM 
TBP 
G1     - 49% 
S        -  7% 
G2/M -  44% 
75/75µM 
TBP 
G1     - 42% 
S        -  5% 
G2/M - 53% 
G1 S G2/M 
G1 S G2/M 
G1 S G2/M 
G1 S G2/M 
G1 S G2/M 
G1 S G2/M 
Untreated	  
Untreated Oxidative stress 
	   93 
 
 
 
 
A. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  B.	   
 
 
Figure 3-3. Immunoblotting for the Oxidative Stress associated Proteins. A. The antioxidant proteins 
SOD1, Catalase and GPX1 levels were changed after cells were treated with TBP. Also, p53 and Cdc7 
accumulated in the treated cells (T) compared to the untreated ones (UT). Actin was used as a loading 
control while the breast cancer (MCF7) cell lines were used as positive (+Ve) control for the antibodies.	  
B. Translocation of Nrf2 & degradation of Keap1 under mild oxidative stress within the IMR90 cells. The 
stability of the Nrf2 protein and down-regulation of the Keap1 protein between the cytoplasmic fraction 
(CF) and nuclear extract (NE) in treated IMR90 cells (OX) in comparison to untreated cells (UT) were 
easily differentiated in both populations.	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3.2.3 Characterisation of the MS data 
 
Three biological replicates were obtained for each fractionated sample (Sn, Sc and St) 
and were subjected to MS. The reproducibility of the sample preparations was verified. 
The data showed that there was a high correlation between each fraction replicate (0.75 
< R2 < 0.88), with the presence of a handful of outliers with some SILAC counts 
(Figure 3-4).  
The MaxQuant software package (Cox and Mann, 2008, Cox et al., 2009) was used to 
identify proteins and determine SILAC ratios for 12 data sets: (1) each nucleus (N) 
sample replicate and the union of the three N samples, (2) each cytoplasm (C) sample 
replicate and the union of the three C samples, and (3) each C&N replicate and the 
union of the three C&N samples. C&N indicates that for each individual replicate, the 
MS data for the C and N samples were jointly processed with MaxQuant to estimate 
changes in total protein abundance (T). The analysis revealed that from 3589 
independent consensus proteins, 1929 were detected in the C and 2751 proteins were 
detected in the N. The protein distribution over the nucleus and cytoplasm is shown in 
Figure 3-5A: 783 proteins were detected only in the cytoplasm, 1605 proteins only in 
the nucleus and 1146 were detected in both locations. A further 35 proteins were 
detected only in T. Among the C and N proteins, there were many proteins with a large 
number of sequenced peptides/ratio counts, which further validated the subcellular 
fractionation efficiency and showed that there were many proteins characteristic of one 
or other of the locations. With at least 2 peptides (1 unique) and 3 ratio counts in a 
single sample, SILAC ratios were obtained for 1658 cytoplasmic proteins (Sc), 2503 
nuclear proteins (Sn), 3199 total proteins (St) and 981 proteins were obtained in all three 
fractions (Sc, Sn, St) (Supplementary Table 1, external CD).  
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Figure 3-4. Correlation of SILAC Ratios between Three Replicates for the Nucleus, Cytoplasm and 
Total samples. All proteins with ≥ 3 ratio counts were included in the calculation of correlation. There is 
a strong correlation between replicates, even in the presence of a handful outliers of low MS recorded 
intensity.  
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Figure 3-5. Venn Diagrams for Protein Distribution over the Nucleus and Cytoplasm. A. 
Total number of detected proteins. From a total of 1929 C proteins and 2751 N proteins, only 
783 proteins were present in the cytoplasm and 1605 proteins only in the nucleus, with 1146 
proteins found in both. B. Significant compartmental abundance protein. From 121 significant 
(SigB) detected proteins: 6 were found only in C, 28 in N and 87 were present in both.  
1605!783! 1146!
C" N"
28!6! 87!
C" N"
detected! 121-OxS set!
	   97 
Protein ratios were normalized (log2 SILAC) in MaxQuant for each data set by the use 
of an algorithm within the Perseus program to calculate an outlier probability score 
(Significance B score, hereafter SigB) (Cox and Mann 2008, Cox, Matic et al. 2009). 
Also, the parameter log2 (Sn/Sc), which aims to detect redistribution between C and N, 
was accompanied with SigB to find the most significant proteins. It was found that, for 
each of the 12 data sets, there were 121 significant proteins (121-OxS): 6 proteins only 
in C, 28 only in N, and 87 proteins were found in both (Figure 3-5B). These 121 
significant proteins accounted for around 3.4% of all of the identified proteins and 
consisted of the changed proteins in Sn, Sc, St and/or the redistributed proteins between 
the nucleus and cytoplasm Sn/Sc under oxidative stress. With the rigorous selection of 
significant proteins: a minimum of 9 ratio counts (in a single sample type) and a median 
of 120 ratio counts per protein were used to classify the proteins within the 121-OxS 
set. It was found that there were 19 highly significant proteins in (Sc), 63 proteins in 
(Sn), 76 proteins in (St) and 43 proteins in (Sn/Sc) (Supplementary Table 2, external CD). 
 
3.2.4 Overlook of the High Enrichment Nucleus Sample 
 
There is growing evidence that some proteins have more than one subcellular location 
and may show different cellular functions in each location (see Discussion). The cellular 
component annotations (GO CC) for many proteins that were quantified in the nucleus 
sample N showed that proteins were annotated to other subcellular locations 
(Supplementary Table 1, external CD). For example, there were 371 proteins present 
within the nucleus sample and annotated to the mitochondria with 147 of them being 
located in the nucleus as well. Also, around 208 proteins were assigned to the 
endoplasmic reticulum as well, and there were other proteins ascribed to other 
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subcellular locations and present within the nuclear sample (Figure 3-6A and GO CC in 
Supplementary Table 1, external CD).  
To ensure that the 121-OxS set was not contaminated with other subcellular organelle 
proteins, the distribution of the functional SILAC ratio of the nucleus to total SILAC 
ratio Sn/St, which is mathematically equal to the nuclear fraction stimulated to the 
nuclear fraction unstimulated (Sn/St = fs/fu), was measured (Figure 3-6, 3-7). It showed 
that the ratio of Sn/St was equal to 1 for most annotated proteins to mitochondria or to 
the other organelles, which means that there is no notable change in the nuclear fraction 
in response to oxidative stress. Only a small number of proteins such as HK1 and BAX 
were found to exhibit changes in the fs/fu ratio. In contrast, in total abundance, these 
proteins showed no or small changes (HK1 St = 1.14, and BAX St = 1.04). For further 
validation, the high abundance proteins that were present in the nucleus sample were 
investigated. It has been found that large numbers of these proteins, which were present 
in the nucleus sample with high subcellular fractionation reproducibility and very minor 
cross contamination from the other organelles, showed no change in measured fs/fu 
(Figure 3-6B). For example, prohibitin (PHB), which is annotated to several cellular 
functions such as apoptosis, cell differentiation and proliferation with known function in 
the organelles, nucleus, mitochondria and the plasma membrane, was a highly abundant 
protein in the nuclear fraction that is annotated to the mitochondria with no change in 
fs/fu and log2 (fs/fu) = 0.009.  
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A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-6. Analysis of the Enrichment of the Nuclear Fraction. A. The table illustrates the 
number of quantified proteins in the nuclear fraction annotated to other subcellular sites with 
significant changes in their nuclear fraction (fs/fu = Sn/St). B. Log2 (Sn/St) for selected high 
abundance proteins to number of SILAC ratio counts includes that at least 50 nucleus proteins 
have GO CC annotation for multiple subcellular locations.  
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Figure 3-7. Proteins Detected in Nucleus with Annotation to other Organelles Subcellular 
Locations. Plots of log2 (Sn/St) to the average number of SILAC ratio counts over the nucleus 
and total data sets for proteins with GO CC annotation to the indicated subcellular organelles. 
For each of the subcellular organelles, the set of proteins was divided into two groups: those 
annotated to the location and the nucleus (red data points); and, those annotated to the location, 
but not to the nucleus (blue data points).  
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3.2.5 Correlation of Changes in Abundance and Nucleus/Cytoplasmic Distribution 
 
Correction for the enrichment of nuclear proteins in the MS data analysis was obtained 
during the estimation of total protein abundance (St). The measurement and correction 
of St value is important to increase the number of proteins as much as possible to 
analyse subcellular redistribution and also to normalise the distribution plane. 
 It was estimated using the following equation: 
 
 𝑆! = 𝑆!∗ !!!!∗!! ! !!!!!!∗! !!!!∗!! ! !!!!!!∗ !!!!! !!!!∗!! ! !!!!!!∗!!!! !!!!∗!! ! !!!!!!∗     
  
When each given value was based on the spatial razor model (see introduction) and r 
was the nuclear enrichment factor these were calculated as follows: 60 µg of 
nuclear/cytoplasmic proteins was used for the MS analysis of each biological replicate, 
the fractionation gave about 250/1450 µg of nuclear/total proteins, which were effective 
enrichment for the nuclear proteins by r = 5.8-fold during the MS analyses. The St*, 
which was the corrected value of St was found to be equal to (r An,s + Ac,s)/ (r An,u + 
Ac,u). The calculations showed that only small protein amounts were modified 
appreciably by correction for nuclear protein enrichment, with only 22 OxS proteins 
showing less than 10% variation between St and St* (Figure 3-8). 
Protein redistribution to/from the nucleus was directly measured by the following 
equation: Sn/Sc = fs(1-fu)/fu(1-fs); when: fu = (St-Sc) and fs = Sn(St-Sc)/St(Sn-Sc) (see 
introduction). Next, 87 significant proteins from the 121-OxS set in the nucleus and 
cytoplasm (Supplementary Table 2, external CD) were tested to find a correlation 
between the changes in total abundance (St) and changes in the nucleus-cytoplasm 
distribution (Sn/Sc). It showed that there was a very small correlation because changes in 
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compartmental abundances were not reflected by the changes in total protein abundance 
(Figure 3-9A).  
The orthogonal 3D spatial razor plot for Sn/St, Sc/St and St was used to characterise the 
response of these significant proteins to oxidative stress. The subcellular spatial razor 
basis set reflects the alterations in the total protein abundance along an St axis with 
changes in the nucleus/cytoplasm distribution in an (Sn/St, Sc/St) distribution plan, which 
is different from total abundance (Mulvey et al., 2013, Pinto et al., 2014).  
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Figure 3-8. Effects of Nuclear Enrichment during MS data Collection on Values of St and 
on the Estimation of basal Nucleo-Cytoplasmic distribution. A. Variation of (St*/St) for 
different values of the nuclear enrichment factor r with unstimulated nuclear fraction fu = 0.5 
and variation of the stimulated nuclear fraction fs over the range fs = 2
-7 -> 0.5 -> 1 – 2
-7 in steps 
of 2
-n
. B. Variation in the subcellular distribution plane. C. Correlation between corrected (St) 
and uncorrected (St*) changes in total abundance for the experimental MS data for the treatment 
of IMR90 cells with TBP. 
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To maintain the mass while using this distribution plan, it was obligatory for the protein 
points to appear in the two allowed quadrants that corresponded to N à C and C à N 
redistribution, respectively (Figures 3-9 B and C).  
The 3D razor model was affected by three variations: changes in total abundance, 
compartmental protein redistribution between the nucleus and the cytoplasm in 
stimulated cells and the original nuclear/cytoplasm distribution in unstimulated cells. 
For example, the 3D razor model for 121-OxS protein data set reveals that, under 
classic oxidative stress, proteins such as light and heavy ferritin subunits (FTL, FTH1) 
showed a significant increase in total abundance with little or no C ßà N 
redistribution, while the seven units of the protein-folding complex CCT showed no or 
slight changes in total abundance; however, there were significant changes in C à N 
redistribution. Proliferation cell nuclear antigen (PCNA) was redistributed from N à C 
with little or no changes in total protein abundance. The log2 (Sc/St) for both CCT and 
PCNA proteins were equal to 0, which meant that the basal abundance of these proteins 
was clearly deviated to the cytoplasm. Also, under oxidative stress, only a small amount 
of CCT proteins was increased in the nucleus and a small amount of PCNA was moved 
to the cytoplasm. ETHE1 protein was also skewed to the cytoplasm in the basal 
abundance, but with a substantial decrease in total abundance and C à N redistribution 
(Figure 18C). Alternatively, the nucleoside diphosphate kinase A (NME1) protein had 
weaker skewing in basal abundance, no changes in total abundance, was redistributed 
from C à N, and might represent a more general “balancing” of function between 
different subcellular locations.  
In contrast, other proteins such as ATP synthase six subunits (ATP5) appeared to show 
changes between total abundance and subcellular distribution. It has been found to 
present a 2-fold decrease in total abundance and was redistributed from N à C; basal 
abundance was skewed to the nucleus, which means that these proteins were more 
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depleted in the nucleus. Also, V-type proteins ATPase (ATP6) were skewed to the 
nucleus, showing a 1.8-fold increase in total abundance and Cà N redistribution.  
The 87 most significant protein distributions (Supplementary Table 2, external CD) 
between nucleus Sn, cytoplasm Sc and nucleus-cytoplasm distribution Sn/Sc are 
summarised in Figure 3-10 and published in (Baqader et al., 2014). Figure 3-10 shows 
the significantly increased/decreased changes in protein abundance and their 
translocation between the nucleus and the cytoplasm. By extracting GO ontology terms 
from Supplementary Table 2 of the121-OxS set, Figure 3-10 illustrates the shared 
functional processes for each protein group. For example, cell differentiation included 
proteins that were also annotated in ATP synthesis, lipid metabolism, haem/iron 
metabolism, the negative regulation of apoptosis, cell adhesion, proline regulatory axis 
and protein transport.  
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Figure 3-9. Subcellular Characterisation of the 87 Proteins of the 121-OxS set for which 
Sn, Sc and St were all measured. A. Plot of changes in nuclear-cytoplasmic distribution (Sn/Sc) 
versus changes in total abundance (St). The red bounding box corresponds to 1.5-fold changes in 
total abundance and 0.57 > Sn/Sc > 1.74 (|log2(Sn/Sc)| > 0.9). A few proteins appear just inside 
the red boundaries because the combinations of basal distribution, changes in total abundance 
and changes in distribution can lead to individual compartmental abundances (Sn or Sc) being 
selected as significant. B. The 3D spatial razor plot for the 87 proteins. The dotted green lines 
correspond to the bound |log2(Sn/Sc)| = 0.8. Changes in total abundance (vertical dotes) are 
colour-coded according to the scale on the right. C. As for plot B, 3D spatial razor plot for 
selected, labelled proteins or protein complexes. Figure were designed by JGZ and published in 
(Baqader et al., 2014). 
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Figure 3-10. Visual Summary of the most Significant Changes in Protein Abundance and 
Distribution that were Quantified in the 121-OxS data set in both Nuclear and Cytoplasmic 
Compartments. The GO terms for biological processes were annotated to the proteins (for more details 
see GO BP in Supplementary Table 2, external CD). Proteins labelled with (red) mean proteins were 
significantly increased in abundance either in nucleus or cytoplasm, while proteins labelled with (green) 
mean proteins were significantly decreased in abundance due to the oxidative stress. Arrows in (blue) 
represent the proteins translocation between nucleus/cytoplasm, while (black à) arrows denotes no 
translocation in response to oxidative stress. Arrows in black without sharp edges (−) mean there is no 
evidence for their translocation.  Figure was designed by JGZ and published in (Baqader et al., 2014).  
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3.2.6 Validation of Translocation for Selected Proteins 
 
To validate several aspects of MS analysis in response to oxidative stress in order to 
check for the presence of some proteins in locations that are different to their original 
ones and to investigate the intact of subcellular organelles under various treatments, 
fluorescence imaging was used for validation of the results. First, to ensure that 
oxidative stress was mild and did not destroy the cellular morphology, images of the 
mitochondria and nucleus were taken. In comparison to the control, the stimulated 
IMR90 cells appeared intact and normal, with no alterations in mitochondria or 
breakage in nucleus structure (Figure 3-11A). Second, there were several groups of 
significant proteins that are well known to be present in specific locations that were 
found in the nucleus fraction. These groups included proteins such as ATP5 synthase 
subunits, which are known to play a role in the mitochondrial respiratory chain. 
ATP5A1 protein distribution within the intact nucleus under oxidative stress was 
investigated. It has been found that, in both stimulated and unstimulated IMR90 cells, 
ATP5A1 was widely distributed over the different subcellular locations such as the 
nucleus and mitochondria and generally was distributed over the cell (Figure 3-11B). 
Moreover, the GO CC for ATP5A1 was found to annotate this protein to nucleus, 
mitochondria, plasma membrane and the extracellular region. Another protein that was 
also checked was Delta-1-pyrroline-5-carboxylate synthase (ALDH18A1). ALDH18A1 
is a main proline regulatory axis protein that was found in the 121-OxS data set with a 
2-fold decrease in nucleus abundance under oxidative stress. Although the confocal 
images (Figure 3-11C) showed that the protein was redistributed from the mitochondria 
to the cytoplasm under oxidative stress, trace amounts of the protein were present 
within the nucleus in both control and treated cells. Also, ALDH18A1 seemed to be 
more condensed under oxidative stress. The GO annotation for this protein also showed 
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that ALDH18A1 was annotated to the cytoplasm, plasma membrane and mitochondrial 
membrane. 
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Figure 3-11. Validation of MS result with Fluorescence Imaging. A. The use of Mito-tracker (green) for 
the mitochondria and Hoechst 33342 (blue) for the nucleus to check the intact cellular morphology under conditions 
of oxidative stress. In both control and treatment conditions, cells appear intact, with no breakage in the nucleus or 
changes in the mitochondria. B & C. Confirmation of selected proteins ATP5A1 and ALDH18A1 by using 
fluorescence confocal microscopy. To verify the MS results in response to oxidative stress, two of the most 
significant mitochondrial proteins were shown to redistribute between the nucleus and cytoplasm data sets under 
oxidative stress; changes in the nucleus of the intact IMR90 were selected. Nuclei (DAPI blue), mitochondria (Mito-
tacker red) and applied antibodies (green) to target proteins of interest for both treated and untreated cells were used. 
The secondary antibody for both primary antibodies was FITC. The fluorescence imaging of ALDH18A1 and 
ATP5A1 showed similar staining pattern that is already known in the literature. B. ATP5A1 appears to be widely 
distributed over nucleus, mitochondria and even the cytoplasm in both treatment and control populations. C. 
ALDH18A1 was similar to ATP5A1; however, after oxidative stress, the proteins seemed to become more 
concentrated and condensed compared to the control. 
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In Table 3-1, the GO term for cellular component GO CC was also used to validate the 
annotation of the 121-OxS set proteins. Table 3-1 shows that there were 117 proteins 
annotated to several locations; each protein seemed to share at least 3 locations, with the 
maximum being 8 locations. For example, 45 proteins were annotated to the nucleus 
and with 31 proteins to the cytoplasm, 18 proteins to the extracellular region and 9 
proteins also to the plasma membrane. In the cytoplasm, of the 64 proteins, 34 were 
annotated to the cytosol with 13 in the mitochondria. However, GO CC seemed to 
underestimate the protein scattering over the different subcellular locations by 
annotating 10 of the shared proteins between nucleus and cytoplasm only to the nucleus 
and 33 of the proteins that were quantified in nucleus and cytoplasm only to the 
cytoplasm.  
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Table 3-1. Distribution of GO CC Annotations for the 121-OxS Proteins set Over the Subcellular 
Locations (Baqader, Radulovic et al. 2014).  
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3.2.7 Functional Network Analysis  
 
The 121-OxS proteins set were inserted in the STRING programme for functional 
network analysis and visualised by Cytoscape. Interactions were investigated for three 
data sets: the 121-OxS; 240-OxS set that contained an additional 119 STRING 
suggested white nodes; and 173-OxS set that contained the 121-OxS set plus 52 nodes 
of the 119 white nodes which were quantified in the experiments but were not 
significant in the MS data. The MCODE clustering algorithm was also used with these 
data to identify clusters of nodes with dense interactions (see materials and methods).  
GO BP enrichments were calculated by BiNGO (Maere et al., 2005) and the functions 
associated with protein clusters were identified by DAVID (Huang da et al., 2008).  
The initial investigation of the 121-OxS by STRING was represented by a connection 
between the protein clusters even in the presence of some disconnected proteins (Figure 
3-12). The clusters of connected proteins included ATPases, proline regulatory axis and 
CCT complex. However, there were some dots that appeared weakly connected or 
disconnected. For example, classic oxidative stress proteins FTL, FTH1 and HMOX1 
appeared weakly connected by STRING. There were around 49 significant proteins 
such as PGRMC1, which is known to be involved in haem binding, and HK1, which is 
an important enzyme for glucose phosphorylation; these both appeared disconnected.  
For 121- 240- 173-OxS data analysis, Table 3-2 showed most of the proteins with GO 
biological functions that were annotated to. The 240-OxS data described the most likely 
main functional processes and the 173-OxS measured exactly how these functional 
processes were monitored in experimental data; the 121-OxS set reflected the pure 
probability which might be small if only a few proteins in the network were monitored 
in experimental data; the 121-OxS set reflected the pure probability which might be 
small if only a few proteins in the network were changed. 
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Figure 3-12. STRING Interaction Network Analysis for 121-OxS set. This shows clusters of 
connected proteins such ATPases, proline axis and CCT complex (red dashed circles). 
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Table 3-2. GO BP “Biological Process” term Associated with STRING Networks. 
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Figure 3-13A shows the STRING network analysis for 240-OxS and suggests different 
protein behaviours under oxidative stress. It indicates that some proteins such as ATP5 
subunits showed similar behaviours in the data (i.e. decreased St with Nà C 
distribution), while the V-type proton ATP6 proteins showed inverse behaviours (i.e. 
increased St with Cà N distribution). There were 47 quantified proteins in the MS data 
of proteasome protein complexes, and 16 were present in 240-OxS, with 14 quantified. 
However, only three of these proteins, PSMD-5, -6 and -11, were quantified in 121-OxS 
data, which were increased in St, showed Cà N distribution, and were annotated to the 
biological process term GO:0071158, “positive regulation of cell cycle arrest”. For the 
nuclear COPS signalosome complex, nine proteins were presented and quantified in the 
240-OxS network. However, only COPS3, ATP5A1, ATP5A69 and HSP1A1 were 
present and quantified in the 121-OxS set. COPS3 and HSP1A1 showed different 
behaviours than ATP5A1 in 121-OxS. For the CCT protein complex, all eight proteins 
were involved in the de novo post-translational protein folding (Table 3-2) and 
quantified in the 121-OxS data with St ~ 1 and presented Cà N distribution. RFC 
proteins (DNA polymerase delta subunits, replication factor C subunits) suggested that 
there was a connection between oxidative status and the cell cycle, although there were 
clear clusters of proteins associated with different specific cellular functions in 240-
OxS. Proteins such as FTL, FTH1 and HMOX1 were still weakly connected with 35 un-
connected proteins in 240-OxS.  
Figure 3-13B shows thumbnails for the significant protein interactions in Sn, Sc, St and 
the Sn/Sc distribution within the 121-OxS set. Only 76 significant proteins that were 
changed in St were selected by the analysis. The SigB for 39 of these proteins was even 
smaller in Sn and Sc compared to St. However, there were 45 St significant proteins 
including 26 proteins that were changed in the cytoplasm with 9 proteins and in the 
nucleus with 17 proteins dependent on changes in St and Sn/Sc distribution. Also, there 
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were 19 proteins that appeared significant in Sn/Sc, but represented very small changes 
in St. For example, polymerase delta-interacting protein 2 (POLDIP2) was one of those 
proteins that was significant in Sn/Sc even though there was no GO BP for this protein 
suggested by the analysis.	  Some of the RAB proteins, including RAB2, RAB5A and 
RAB5B, were significantly smaller in St as well.  
Analysis also showed that there were some proteins with more than one biological 
function according to their subcellular location. For example, plasminogen activator 
inhibitor 1 (SERPINE1) protein was annotated to 10 GO BP terms including terms 
related to extracellular matrix organisation, cellular component movement, and DNA-
template (Table 3-2; details in Supplementary GO Terms Table, CD).  
GO BP was useful for understanding protein biological functions. However, 4 proteins 
out of 121-OxS had no GO BP terms; also, 89 proteins of 121-OxS only had enriched 
terms in Table 3-2. Additionally, some terms were not reflected in the model that was 
used for the study of IMR90 cells. However, the same functional meaning was still 
given. For example, the term ‘phagosome maturation’ and ‘insulin receptor signaling 
pathway’ reflected lysosomal/endosomal processes. Also, the term ‘de novo post-
translational protein folding” reflected the role of the CCT complex in membrane fusion 
and the term ‘muscle contraction’ was related to endocytotic processes (see discussion).  
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Figure 3-13. Network Analysis for 240-OxS data set Including the 121-OxS set. A. STRING 
interaction network for the 240-OxS set. The protein nodes for the 121-OxS set are coloured in red, the 
nodes for the proteins that were not significant but identified in MS are coloured in yellow, and proteins 
that were not found within the data sets and were only suggested by STRING are coloured in grey. 
Plugging the network with Cytoscape software was used to calculate the node and edge colour and size 
that expressed betweenness centrality values. Note: Betweenness centrality value helps to measure the 
node's centrality and position in a network. Edge Betweenness, which is a topological measure, is known 
as a normalised number of direct routes between two nodes. B. Thumbnails of the interaction network. 
The blue node represented significant protein changes in Sn, St, Sc and Sn/Sc within the 121-OxS data set. 
The network interactions figure was designed by Marko Radulovic (Baqader et al., 2014). 
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3.2.8 The Significantly Affected Metabolic Pathways under Oxidative Stress  
Different important pathways that are related to oxidative stress were examined.  
3.2.8.1 Affected Protein Pathways Related to Nrf2: Nuclear Respiratory Factor 2 is 
known to be involved in different intermediary metabolism processes such as 
glycolysis, the TCA cycle, generation of NADPH, glutamine metabolism, and fatty acid 
oxidation (Hayes and Dinkova-Kostova, 2014). In the present study, the Nrf2 protein 
was found to translocate to the nucleus under oxidative stress by the use of WB (Figure 
3-3B). Thus, Nrf2-related pathways were investigated within the present data set by 
using a recent collocation of positive Nrf2-regulated genes as a reference. For example, 
Nrf2 was known to cause changes in pathways related to glycolysis and pentose 
phosphate, producing NADPH, which is important for antioxidant proteins (Hayes and 
Dinkova-Kostova, 2014). Numerous proteins in this pathway were observed in the 
study (Figure 3-14A) as follows: there was little change in total abundance detected in 
either of the isoforms of pyruvate kinase (St = 1.08, 0.99) or in the enzymes 
G6PD/PGLS/PGD (St =1.12, 0.94, 1.04) in the oxidative arm of the pentose phosphate 
shunt. The arm of the pentose phosphate shunt included TALDO/TKT, which showed 
slight increases in total abundance (St = 1.08, 1.39). However, MTHDF2 showed a 
significant decrease (St = 0.58), which was thought to slightly increase via 
MTHDF1/MTHDF1L1 (St = 0.96, 0.91). HK 1 was a significant protein in the 121-OxS 
set that was found to translocate from C à N, but was totally disconnected in the 
STRING network (Figure 3-12, 3-13). It was found to be the only significant protein in 
the glycolysis pathway (Figure 3-14A). HK1 was found to rely on redistribution of the 
subcellular location (St = 1.14, Sn = 2.02, Sc = 1.10, log2 (Sn/Sc) = 0.87). For the TCA 
cycle (Figure 3-14B), it has been found that 12 of the TCA cycle enzymes (SUCLA2, 
SUCLG2, FH, MDH2, MDH1, IDH2, IDH3A, IDH3B, IDH3G, CS, ACO2, ACO1) 
showed minor changes in total (0.83 < St < 1.11) or compartmental abundance. 
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Lipoamide E cofactor proteins showed slightly more obvious decreases in abundance 
(DLD, DLST, OGDH; 0.70 < Sn, St < 0.76) with moderate redistribution from N à C 
and SUCLG1 St, Sc were ~0.75. These results were also accompanied with a slight 
reduction of succinyl-CoA production from 2-oxo-glutarate and its subsequent usage in 
the TCA cycle. Lipoamide E proteins of the pyruvate dehydrogenase complex (DLD, 
DLAT, PDHB) showed a similar modest decrease in abundance (0.70 < St < 0.85) and it 
was consistent with reduced production of acetyl-CoA from pyruvate. There was a 
modest decrease in IDH2 (St, Sc ~ 0.91) and a modest increase in cytoplasmic IDH1 (St, 
Sc ~ 1.33); none of these proteins were present in the 121-OxS set of the most 
significantly changed proteins (Figure 3-14B), and the most significant change in the 
TCA cycle was a decrease in SDHA and SDHB (Sn, St ~ 0.37). SDHA and SDHB were 
connected by STRING to ATP synthase (Figure 3-13A).	  
For the NADPH pathway, this is usually regulated via the generating enzymes G6PD, 
PGD, IDH1, 2 and NADP-dependent malic enzyme (ME1), which is known to be an 
alternative enzyme for pyruvate (Hayes and Dinkova-Kostova, 2014). In the present 
study, it was been found that there was a slight increase in abundance for ME1 (St = 
1.19) with a modest change in mitochondrial NAD (P) transhydrogenase NNT (St = 
0.71). Moreover, there were no notable changes detected in the levels of proteins of 
glutathione- or thioredoxin-based anti-oxidant systems. Glutathione peroxidases GPX1 
and GPX8 (St ~ 0.7), glutaredoxin GLRX3 (St = 1.02), isoforms 1 and 3 of glutaminase 
GLS (St = 0.93, 0.83), and glutathione reductase GSR (St = 1.32) were slightly changed 
in abundance. For some antioxidants, it was found that thioredoxin TXN (St = 1.23), 
thioredoxin reductases TXNRD1 and TXNRD2 (St = 1.16, 0.93), and peroxiredoxins 
PRDX1, 2,4,5,6 (0.93 < St < 1.15) were not significantly changed in abundance. Only 
PRDX3 showed slightly different behaviour (St = 0.77, Sn = 0.63, Sc = 0.92). Notably, 
none of these anti-oxidant proteins were amongst the 121-OxS set. 
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For fatty acid oxidation, of the 24 proteins observed, 21 of them showed very small 
changes in total (0.82 < St < 1.19) or compartmental abundance. Significant changes in 
total and nuclear abundance were observed for subunits of the mitochondrial 
trifunctional enzyme HADHA/HADHB (St = 0.65/0.68; Sn = 0.61/0.60; Sc = 0.93/0.97). 
The electron transfer flavoprotein-ubiquinone oxidoreductase ETFDH appeared to show 
similar behaviour, but with a smaller number of SILAC ratio counts. Likewise, many 
proteins associated with the detoxification of drugs whose abundance is controlled by 
NRF2, including oxidation of drugs (aldehyde dehydrogenases, aldo-keto reductases, 
carbonyl reductases CBR1 and CBR3, epoxide hydrolase EPHX1, prostaglandin 
reductase PTGR1), conjugation of drugs (glutathione S-transferases GSTM3, GSTP1, 
MGST1) and drug transport (ABCC1), showed very small changes in abundance. Of the 
many proteins that are associated with drug detoxification, microsomal glutathione S-
transferase (MGST3) showed a modest change (St = 1.33), and multidrug resistance-
associated protein 4, ABCC4 protein (St, Sn = 0.50), was found in the 121-OxS set.	  	  
For glutamine metabolism, which was suggested to be regulated by Nrf2 via glutamine 
synthase (GLS), the pathway-related proteins were viewed in the present study. It has 
been found that isoforms 1 and 3 of GLS, which is part of a group of the “proline 
regulatory axis” proteins (Figure 3-14C) and strongly connected to redox regulation, 
glutamine/proline metabolism, the urea cycle, the TCA cycle, and collagen, showed 
only small changes in abundance (St = 0.93, 0.83). There were strong changes in 
abundance and subcellular distribution for the proline regulatory axis: pyrroline-5-
carboxylate reductase (PYCR1), delta-1-pyrroline-5-carboxylate synthase 
(ALDH18A1), and collagen (COL1A1) in the 121-OxS set which might also affect the 
level of NADH/NADPH and cell cycle arrest.  
However, it appears that antioxidant activities controlled by NRF2 were not a major 
contributor to the response of IMR90 cells with TBP. The activation of Nrf2 by 
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antioxidant response elements (ARE) was checked by studies of their related proteins. A 
strong increase in abundance of the CCAAT/enhancer-binding protein beta CEBPB (St, 
Sn = 2.23) and moderate increases of an accessory protein involved in NRF2 
transcription MAFG (St = 1.48, but with only five SILAC ratio counts) was found. This 
suggested that there was modularity in the transcriptional activity of NRF2 and it was 
found in the present study for proteins involved in iron/haem metabolism and controlled 
by the NRF2. For example, both subunits of ferritin (FTL and FTH1; St = 1.72 and 1.84, 
respectively) and haem oxygenase (HMOX1; St = 7.11) presented strong increases in 
abundance. However, biliverdin reductase (BLVRA) and flavin reductase NADPH 
(BLVRB) did not show increased abundance (St = 1.03 and 1.00, respectively). Catalase 
CAT (St = 0.89) and superoxide dismutases SOD1 and SOD2 (St = 1.34 and 0.77, 
respectively) showed moderate changes as a specific feature of cell response to TBP. 
Catalase and SOD1 showed moderate increases by WB (Figure 3-3). 
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Figure 3-14. The Pathways of Proteins Regulated by Nrf2. The most significant proteins in the 121-
OxS data set were marked in Red; the non-significant proteins in 121-OxS, but which were presented 
within the MS data, were marked in Yellow. Proteins not presented within data were marked Grey. A. 
Glycolysis pathway. B. TCA cycle. C. Proline regulatory axis pathway.  
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3.2.9 Affected Proteins Related to Different Cellular Functions 
 
 
Proteins that relate to different subcellular locations and protein transport, and which 
were present in the 121-OxS data set, were checked. The use of the GO BP database 
showed that, in the present study, there were 448 identified proteins annotated to 
nuclear import/export/localisation/maintenance or regulation with 160 quantified 
proteins; 10 of these were suggested as possible changes in nuclear transport, of which 
five satisfied the more stringent conditions of presence in the 121-OxS set and were 
used in the network searches (Table3-3). For example, the proteins that were included in 
Table 3-3 were suggested by GO BP to be involved in processes related to 
nucleocytoplasmic trafficking; for example, collagen COL1A1 was annotated to 
‘protein localisation to nucleus’ (GO: 0034504) and ‘regulation of canonical Wnt 
receptor signaling pathway’ (GO: 0060828), whereas karyopherin KPNA2 was 
annotated to ‘NLS-bearing substrate import into nucleus’ (GO: 0006607). Generally, 
most of these proteins had more than one process. However, CDKN1A was only 
annotated to a process related to oxidative stress: ‘regulation of reactive oxygen species 
metabolic process’ (GO: 2000377). Some of these proteins were known to be more 
strongly involved in other processes such as HSPA9 protein, which was known to be 
involved with mitochondria.  
Moreover, for	   vesicular trafficking proteins, there were 1175 proteins annotated to 
“vesicle-mediated transport” (GO:0016192) and 503 proteins annotated to “cytoplasmic 
vesicle” (GO:0031410) in the GO database; these included a significant number of 
common proteins. Therefore, the set of 1427 proteins that were annotated to one or both 
of these terms was checked, of which 344 were quantified in the present experiments 
and 100 had annotations to the nucleus. Of the 251 of these proteins that were 
quantified in the nucleus, 70 were annotated to the nucleus (Figure 3-7, 3-8) as well as 
with other subcellular organelles, which showed little or no change in their nuclear 
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fraction and no difference between proteins that were found with/without annotation to 
the nucleus (Figure 3-15). It was also suggested that there was selectivity in the 
nucleocytoplasmic trafficking of these types of proteins. For example, for 29 of the Ras-
related RAB proteins quantified in the present experiments and the 14 proteins that were 
annotated to vesicle-mediated transport, only 3 proteins showed evidence of 
nucleocytoplasmic trafficking following TBP treatment. The 121-OxS set included 28  
nucleocytoplasmic trafficking proteins, of which 27 were quantified in the nucleus and 
8 are presently annotated to the nucleus; 11 of these proteins showed substantial 
changes in the fraction of the protein in the nucleus (|log2(Sn/St)| = |log2( fs/fu)| > 0.5, 
Figure 3-15), including RAB2A, RAB5A, and RAB5B.	  Noteworthy, seven of these 
proteins were involved in iron metabolism (ATP6V0A1, ATP6V0D1, ATP6V1C1, 
ATP6V1H; FTL, FTH1, HMOX1). Also, there were a further 3 proteins involved in 
iron/haem metabolism that are currently annotated to the “vesicular fraction” 
(PGRMC1, POR, PTGS1) and 28 of these proteins were only weakly connected by 
STRING (Figure 3-13A).  
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Table 3-3. Proteins Involved in Nuclear Import/Export/ Localization/Maintenance or its 
Regulation. Proteins with SigB < 0.005 and ≥3 ratio counts for at least one of Sn, Sc, or St. Bold gene 
names satisfied the more stringent conditions for selection of the 121-OxS set. 
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Figure 3-15. Analysis of Proteins Annotated to Vesicular Trafficking. The plot in top illustrates 
log2(Sn/St) = log2(fs/fu) as a function of the average number of ratio counts over the nucleus and total data 
sets for proteins annotated to “vesicle-mediated transport” or to “cytoplasmic vesicle”. Proteins with (red, 
70 proteins) or without (blue, 181 proteins) annotation to the nucleus are indicated. Right: number of 
proteins versus log2(fs/fu). Table: Data for 28 proteins of the 121-OxS data set. 
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3.2.10 Indication of Extensive Participation of Iron/Haem Metabolism and 
Mitochondria 
Proteins that involve iron homeostasis or haem/iron as a cofactor and were substantially 
enriched in the 121-OxS set were checked. In the present data, 93 proteins out of 3124 
quantified proteins, with 20 proteins of the 121-OxS set, were involved in iron or 
haem/iron metabolism. The 20 significant proteins included 19 that were quantified in 
the nucleus; 13 of them represented the most significant changes in Sn, and 6 
represented the most significant changes for St or Sn/Sc. Noteworthy, out of these 19 
proteins, there were 3 that were annotated to the nucleus (ATP6V0A1, HMOX1, 
PGRMC1) and participated in different biological processes. However, their functions 
in the nucleus remain poorly understood. Ten subunits of V-type proton ATPase 
(ATP6) were present in the nucleus but were still not annotated to it yet, as well as both 
ferritin subunits (FTL, FTH1) that are important in iron homeostasis, oxidoreductases 
(CYB5B, CYB5R3, POR) that involve haem proteins and the succinate dehydrogenase 
[ubiquinone] iron−sulfur subunit (SDHB) that depends on an iron−sulfur cluster for its 
activity. Proteins such as haem protein prostaglandin G/H synthase 1 (PTGS1) were not 
quantified in the nucleus but showed a significant decrease in abundance in cytoplasm 
Sc. However, changes in iron metabolism-related proteins appeared to be a response to 
oxidative stress, especially within the nucleus. Only a few proteins, 4 out of the 20 
significant proteins (such as HMOX1 and PTSG1), were annotated to oxidative stress, 
and few of the 19 proteins were functionally annotated to the nucleus.  
For the mitochondrial proteins, 41 proteins of the 121-OxS significant set were 
annotated to the mitochondria, with 39 of them quantified in the nucleus, and 25 of 
them corresponding to the most significant changes for Sn; two proteins (CYB5B, 
ETHE1) corresponded to the most significant changes for Sc, and 12 corresponded to 
the most significant changes for St and/or Sn/Sc distribution. For the molecular functions, 
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only 7 of these proteins, including ATP5A1, ETHE1, HSPA1A, HSPA9, NME1, 
POLDIP2 and PTRF, are currently annotated to the nucleus. Proteins such as 
polymerase delta-interacting protein 2 (POLDIP2, mitochondrial nucleoid 91) and the 
polymerase I and transcript release factor protein (PTRF, transcription from RNA 
polymerase I promoter 92) seemed to play similar roles in both the nucleus and the 
mitochondria and both showed slight increases in total abundance with C à N 
redistribution. The GO biological process for proteins ATP5A1, HSPA1A (co-
localisation with the COP9 signalosome 69), NME1 (positive regulation of DNA 
binding 93), and HSPA9 (poly (A) RNA binding and protein export from the nucleus) 
did not indicate nuclear functions for them. There were also 32 mitochondrial proteins 
with no clearly defined functions in the nucleus detected in the nuclear fraction, with 27 
annotated to the mitochondrial matrix/inner membrane: 10 subunits of ATP synthase 
(ATP5), 2 proteins of the TCA cycle (SDHA, SDHB), 2 proteins of the proline 
regulatory axis (ALDH18A1, PYCR1), mitochondrial peptidases (AFG3L2, LONP1, 
PITRM1, PMPCB), other proteins involved in oxidation−reduction processes (CYB5B, 
CYB5R3, GPD2, HADHA, HCCS, POR, SQRDL), as well as LETM1 (a mitochondrial 
Ca2+ and/or K+ transporter 96) and PTCD1. Only ATP6V1A, ATP6V1E1, CCT7, 
ECH1, HK1, HSPA4, POR and TCIRG1 were known to have another function beside 
their original function as mitochondrial proteins. Seven of the proteins that were 
annotated to mitochondria and detected in the nucleus also belonged to iron/haem 
proteins (ATP6V1A, ATP6V1E1, CYB5B, CYB5R3, POR, SDHB and TCIRG1). 
Furthermore,	  9 of the proteins in the 121-OxS set that were annotated to mitochondria 
(ATP5A1, ATP5B, ATP6V1A, ATP6V1E1, CCT7, ECH1, HSPA1A, HSPA4 and 
HSPA9) were annotated to the extracellular vesicular exosome and one (TCIRG1) was 
annotated to the phagocytic vesicle membrane. For biological processes, only 4 of these 
mitochondrial proteins were annotated to stress responses (HSPA1A, HSPA4, LONP1 
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and PYCR1). Finally, 39 mitochondrial proteins (of the 371 quantified in the nucleus) 
were thought to represent the cellular response to oxidative stress (see discussion).  
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Chapter 4: Discussion of Findings	  	  
 
The proteomics subcellular spatial razor is a powerful approach for the study of 
dynamic changes and protein redistribution between different cellular locations such as 
the nucleus and the cytoplasm. The previously published results related to protein 
distributions during cell cycle arrest in IMR90 cells (Mulvey et al., 2013, Mulvey et al., 
2010), cellular response to oestradiol in breast cancer MCF7 cell lines (Pinto et al., 
2014) and fluorescence-based results on genome-wide spatial response to hypoxia in 
yeast (Henke et al., 2011) all suggested that the subcellular distribution of proteins is 
highly dynamic and context-dependent. In the present experiment, the experimental 
model was based on treatment of the normal human fibroblast IMR90 cell lines with 
tert-butyl-hydrogen peroxide TBP in cell culture to generate a mild oxidative stress 
response within the cells. This was with the aim of arresting cell cycle by activating 
specific cell cycle checkpoints to test the hypothesis that the novel DNA origin 
activation checkpoint response in somatic cells is a normal response driven by a novel 
pathway.  
The subcellular proteomics analysis revealed that there was dynamic redistribution of 
numerous proteins over the defined compartments (i.e. nucleus and cytoplasm) as a 
response to oxidative stress; these findings revealed several aspects of cellular response 
to oxidative stress that are still poorly understood. It is now clear that cellular response 
to oxidative stress and ROS signaling affect different cellular processes. In this 
experiment, these processes were primarily viewed from a nuclear-defined perspective. 
The data discussed four key topics: the first topic covered the general properties of the 
proteomics subcellular spatial razor, especially the compartmentalised changes in 
protein abundance between the nucleus and cytoplasm. The second topic included a 
simple overview of the most significant proteins in the data that are known to 
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participate in different cellular processes such as control of the cell cycle, 
autophagy/mitophagy, and other signaling systems. The third topic provided intensive 
analysis for the two most prominent features that seemed to be related and to be more 
novel in current understanding of cellular response to oxidative stress. This has included 
the participation of proteins that play crucial roles in iron metabolism or with haem/iron 
as cofactors, and how that was connected to nuclear hormone metabolism/receptors that 
are involved in cancer. The final topic generally suggested constructing models of 
cellular function that include functional systems that are spatially distributed over 
different subcellular locations and dynamic changes in the spatial dispersion of proteins. 
To achieve these topics the experiments were firstly optimised to ensure the cellular 
response to TBP. Optimising and testing the cells response to TBP was achieved by the 
use of FACS analysis and western blotting, which helped to select the best dosage that 
caused mild oxidative stress without harming cells. It has been found that a high level of 
oxidative stress can be lethal for cells (Fatemi et al., 2014). Conversely, in the present 
study, from initial light microscopic pictures, cell numbers appeared normal with the 
optimised doses (50-100µM) of TBP, which means that modest dosage might still affect 
the cells without harming them (Figure 3-1). These results were also monitored by the 
use of FACS analysis for the nominated doses to test cell cycle arrest between G1/S 
after the treatment and also to confirm the cellular viability by checking the 
accumulation of dead cells at sub-G1. Accumulation of cells at the G1/S and G2/M 
boundaries with no sub-G1 under oxidative stress indicated that the cell cycle 
checkpoints were activated due to the treatment effect (Figure 3-2); these results were 
also compatible with the previously published results that found cell cycle was 
suspended after the activation of a specific checkpoint, the origin activation checkpoint 
(Tudzarova et al., 2010).  
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Elevation of ROS is known to increase antioxidant levels; for example, SODs normally 
elevate to convert the free radical oxygen into hydrogen peroxide. In contrast, 
antioxidants such as PRX, GPX and catalase participate in protein oxidation and redox 
biology by converting the excess of H2O2 into water. This antioxidants system is mainly 
controlled by Nrf2 (Schieber and Chandel, 2014). Western blotting for most of these 
antioxidant proteins showed modest elevation with TBP (Figure 3-3.A). In a previous 
study of cell cycle arrest at the original activation checkpoint for DNA replication 
induced by knockdown of the Cdc7 kinase by siRNA (Mulvey et al., 2013, Mulvey et 
al., 2010), Cdc7, tumour suppresser p53 and other oxidative stress proteins were shown 
to be involved in the cellular response. In the present study treatment, TBP was found to 
cause changes to both Cdc7 and TP53 in IMR90 cells (Figure 3-3A), highlighting that 
the cell cycle and oxidative stress have functional overlaps (Burhans and Heintz, 
2009a). In parallel, translocation of the Nrf2 protein from the cytoplasm to the nucleus 
after the indication of oxidative stress provided evidence that the ROS level and 
antioxidant systems were activated due the TBP effect (Figure 3-3B). Thus, these 
results were suitable for proceeding with proteomic investigations. 
 
4.1	  Properties of the Subcellular Spatial Razor  
 
A general overview of the results has shown that large numbers of either significant or 
non-significant proteins that were found in the nucleus were annotated by GO to 
different subcellular locations. The protein set of each organelle (Figure 3-6, 3-7) 
proved that a small number of the proteins, which were annotated to non-nuclear 
locations, represented changes in compartmental abundance as a response to oxidative 
stress. The changes in protein abundance between different subcellular organelles were 
obtained via a combination of changes in the subcellular distributions and total 
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abundance, with redistribution being at least equally important as changes in the total. 
The consistency of the results proved that there was no artefact from nuclear 
enrichment; this was also found with previously published experiments, making the 
results more reliable. For example, 36% of human proteins within the GO database are 
annotated to different subcellular locations. Also, the previously published spatial razor 
results for Cdc7 knock-down in IMR90 cells related to cell cycle arrest showed the 
same context, whereby nuclear enrichment was achieved by the same protocol with only 
14 significant proteins shared between the two data sets (Mulvey et al., 2013). By 
comparing the significance of these two data sets of Cdc7KD (here after, origin 
activation checkpoint, 124-OAC) and 121-OxS (Supplementary Table 4, 5, external 
CD), a high variation in abundance and distribution has been found as a response to 
different cellular stimulations. The TCA cycle, glycolysis and proline regulatory axis 
were checked in both data sets. For glycolysis, HK1 showed strong reduction under 
oxidative stress, but was not significant under the Cdc7KD data set. For the proline 
regulatory axis, the significant proteins in the 121-OxS set were PYCR1 and 
ALDH18A1; in contrast, GLS, GLUD1 and OAT were changed in the Cdc7-depletion 
data set. Proteins such as collagen (COL1A1) were significant in both but were 
decreased in OxS and increase in Cdc7KD. In relation to TCA cycle, 6 proteins include 
ACO2, DLD, FH, IDH2, MDH2, and SUCLG1 were significant in the nucleus for the 
Cdc7KD data set (Mulvey et al., 2013), whereas only SDHA and SDHB had changes 
detected in the 121-OxS data set.	  Hypoxia is also known to be a form of oxidative stress 
and genome-wide scans of subcellular protein distribution in yeast cells in response to 
hypoxia (Henke et al., 2011) resulted in the redistribution of SDHA.	  The spatial razor 
showed the changes in these three pathways in both data sets. The selectivity/reliability 
of the subcellular spatial razor was proven by direct comparison of the proteome of 
mitochondria and nuclei in MCF7 breast cancer cells. In these experiments, nuclei were 
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enriched with similar protocols as well. The results from MCF7 cells revealed that there 
were around 1000 proteins separated into the two subcellular locations and that this 
separation was highly reproducible (Qattan et al., 2012). Stimulation of MCF7 cells 
with oestrogen results in the major nucleocytoplasmic redistribution of proteins, which 
encompassed more than 100 proteins detected in the mitochondria (Pinto et al., 2014). 
This allowed us to conclude that the subcellular redistribution is more prominent than 
changes in total abundance, which led to the hypothesis that strong perturbation of 
subcellular spatial control may be a main feature of cancer cells (Pinto et al., 2014). In 
IMR90 cells, there was no massive nucleocytoplasmic redistribution detected in IMR90 
cells under oxidative stress or cell Cdc7 depletion related to cycle arrest. However, it 
has been found that oestrogen receptor alpha (ESR1) was prominent in the 240-OxS 
STRING network (Figure 3-13) and there were no changes detected for proteins with 
direct connections to a progesterone receptor in the 121-OxS set. Although there is still 
the need for technical improvements in the proteomics experimental procedures, the 
nuclear spatial razor provides important information on the role of nucleocytoplasmic 
subcellular redistribution in cellular function. The spatial razor approach can also be 
applicable to other subcellular organelles such as mitochondria. 
 
4.2 Overview of Cell Cycle Control, Autophagy/Mitophagy, Signaling Systems, 
and Mitochondrial Response 
 
4.2.1 Cell Cycle Control 
 
It is already known that there is a strong relationship between oxidative stress and the 
cell cycle (Burhans and Heintz, 2009b, Chiu and Dawes, 2012). However, it was 
initially surprising that only a few common proteins were strongly altered between 
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oxidative stress and cell cycle arrest within the IMR90 cells (Supplementary table 6, 
external CD). Noteworthy, by including proteins that showed similarities and 
differences in the joint analysis of the two data sets, oxidative stress and cell cycle 
arrest, there were a variety of nuclear processes and DNA replication that were 
changed in similar ways. However, these changes were achieved by detecting subtle 
alterations in the protein identity, total abundance, and protein redistribution of 
numerous proteins that were involved in the process; for example, polymerase delta-
interacting protein 2 (POLDIP2), the homozygous deletion of which is lethal in mice 
(Sutliff et al., 2013), was detected within both data sets. POLDIP2 is already known to 
have functional roles that involve binding to DNA polymerases and ubiquitinating 
PCNA in the nucleus. These functions were suggested to offer cells the ability to 
bypass lesions such as 8-oxo-7, 8-dihydroguanine during DNA replication (Liu et al., 
2003, Maga et al., 2013, Tissier et al., 2010). It has also been found to participate in 
the formation of mitotic spindles and chromatin segregation (Klaile et al., 2008). 
POLDIP2 has also been shown to be involved in the spliceosome and is essential for 
alternative splicing of MDM2 in response to UV irradiation, possibly as a 
consequence of ROS signaling (Wong et al., 2013). This also can be related to p53 
(Dutertre et al., 2011), as p53 induces the transcription of HMOX1 (Nam and 
Sabapathy, 2011) and haem interactions (Shen et al., 2014). It has been reported that 
the plasma membrane interaction with CEACAM1, which is the homophilic cell−cell 
adhesion receptor carcinoembryonic antigen-related cell adhesion molecule 1, is 
related to the nuclear import of POLDIP2 under specific conditions such as 
quiescence, proliferation and cell division cycle (Klaile et al., 2007). Related to the 
reduced production of H2O2 and increased collagen secretion in focal adhesions and 
stress fibres, with the aim of regulating ROS signaling, extracellular matrix 
composition, and vascular structure and function in mice, NOX4 enzymes, which are 
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ROS-generating proteins, have been found to interact with POLDIP2 (Lyle et al., 
2009, Sutliff et al., 2013).  
In our data sets, a massive increase in nuclear abundance for POLDIP2 (Sn = 1.79) 
coupled with increases in total abundance with C à N redistribution (St = 1.67, log2 
(Sn/Sc) = 1.18) and moderate decrease in cytoplasmic abundance (Sc = 0.79) were 
observed. Joint analysis with Cdc7-depletion-induced cell cycle arrest, in relation to 
DNA replication, showed that the proteins POLD and PCNA, and the replication 
factor C complex, were all included in the 240-OxS set (Figure 3-13, and 
supplementary table 3). Although the relative amounts of POLDIP2 over the different 
subcellular locations are not clear (Klaile et al., 2007), POLDIP2 has been found to 
have a mitochondrial targeting sequence in order to be predominantly expressed in the 
mitochondria of certain cell types (Cheng et al., 2005, Xie et al., 2005). It is also 
known to be associated with TFAM and LONP1 proteins in the mitochondrial 
nucleoid (Cheng et al., 2005). It not surprising therefore that POLDIP2 may be a link 
between DNA metabolism in the nucleus and mitochondria in related ROS signaling 
systems. Noteworthy, the POLDIP2 gene, which is known to be part of the complex 
sense-antisense architecture, has been linked with ERBB2, which is a member of the 
epidermal growth factor family, and associated with breast cancer (Grinchuk et al., 
2010).  
 
4.2.2 NRF2 and FOXO Signaling Systems 
 
NRF2-related signaling is important in the response to oxidative stress and control of 
the antioxidants system (Ray et al., 2012, Hayes and Dinkova-Kostova, 2014, 
Pickering et al., 2013, Schieber and Chandel, 2014), and was clearly predominant in 
our experiments. Although NRF2 is known to affect glycolysis, the TCA cycle, 
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NADPH generation, and antioxidant systems, NRF2 response on these pathways 
seemed not predominant in our experiments (Figure 3-14). However, NRF2 
expression clearly led to activation of antioxidant response elements (i.e. up-regulation 
of CEBPB, MAGF) and haem/iron proteins under NRF2 transcriptional control 
(HMOX1, FTL, FTH) including the strongest alterations in total protein abundance. 
Connection between p53, cell cycle processes and Nrf2 signaling, are believed to be 
coordinating via the FOXO transcription factor (Tudzarova et al., 2010, Sainsbury et 
al., 2010, Gorrini et al., 2013). FOXO is also known to participate in mitochondrial 
ROS signaling and the apoptotic pathway (Hagenbuchner and Ausserlechner, 2013). 
In our data set, it was found that 269 proteins were quantified and functionally 
annotated to apoptosis, with 16 of them being significant in the 121-OxS data set 
(supplementary table 2, external CD). These proteins were equally divided between 
anti-apoptosis proteins (SERPINE1, HSPA1A, HMOX1, HSPA9, POR), apoptosis 
proteins (LGALS1, PSMD6, PSMD5, NME1, PSMD11), or both (RPS27A, 
SQSMT1). Also, a similar mixed pattern was detected for the positive or negative 
regulation of apoptosis, with no clear patterns of changes in total or compartmental 
abundances that differentiated between apoptosis/anti-apoptosis. GO showed that 28 
proteins were annotated to caspase activity (GO:0004197) or regulation of cysteine-
type endopeptidase activity involved in apoptotic processes (GO:0043281), with only 
thrombospondin-1 (THBS1) being included in the 121-OxS set. These proteins have 
several other activities. Although, the data are consistent with a modular response to 
TBP, these did not include FoxO3-mediated connections to apoptosis. This led us to 
postulate that the data were consistent with no visible increase in dead cells and only 
very small changes in Annexin A5 (St = 1.09). This was suggested modularity in the 
NRF2-related response to TBP and other interactions involving NRF2; in particular, 
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the transcription of haematopoietic proteins and interaction with SQSTM1 may be 
crucial.  
 
4.2.3 Autophagy and Sequestosome-1 (p62/SQSMT1)  
 
In our data, GO annotated 10 quantified proteins to autophagy; these proteins included 
PARK7, FIS1, NPC1, and GABARAPL2 (Supplementary table 2, external CD). 
P62/SQSMT1 was the only protein found within the 121-OxS set, which has been 
shown to play a crucial role in autophagy as a response to oxidative damage (Szeto et 
al., 2006) and has a protective effect in	  huntingtin-induced cell death by lowering p26 
levels (Bjorkoy et al., 2005). In other studies, SQSMT1 in association with Parkin has 
been found to be involved in the clustering of mitochondria in the perinuclear region 
(Okatsu et al., 2010) but not in mitophagy (Narendra et al., 2010). In promyelocytic 
leukaemia bodies, p26/SQSMT1 was found to translocate from the cytoplasm to the 
nucleus via NLS import/export sequences under phosphorylation control for the 
targeting of proteins for degradation (Pankiv et al., 2010). Under oxidative stress, 
SQSMT1 has been found to bind to Keap1 and help to initiate Nrf2 activation through 
the creation of a feedback loop (Komatsu et al., 2010, Jain et al., 2010). It is also 
known that, under stress, SQSMT1 plays a role in the formation of protein aggregates 
in the perinuclear region which are to be degraded by selective autophagy. However, 
this finding of protein aggregates was not sufficient to explain the observation of 
dynamic nucleocytoplasmic distributions in our data. For example, in our data, 371 
unstimulated mitochondrial proteins were detected in the nucleus with only 41 
quantified in the 121-OxS data set. Thirty-nine of mitochondrial proteins within the 
121-OxS data were found to increase and decrease in nuclear abundance with protein 
redistribution between the nucleus and cytoplasm, with little or no change in total 
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abundance (Figure 3-9, 3-10; supplementary Table 2, external CD). It was suggested 
that SQSMT1 might have additional roles in the nucleocytoplasmic trafficking of 
(ubiquitinated) proteins as well as its role in the aggregation of damaged proteins such 
as PCNA, which binds both POLDIP2 and Flap endonuclease 1 (FEN1) (Sakurai et 
al., 2005). Many autophagic proteins have different roles (Subramani and Malhotra, 
2013) and SQSMT1 might have other roles as well. In our data, GO showed that 
SQSMT1 was annotated to the negative regulation of apoptotic processes and small 
GTPase-mediated signal transduction (Table 3-2) which indicates that SQSMT1 might 
be more directly connected with changes related to cancer and interactions with 
mTOR in lysosomes (Moscat and Diaz-Meco, 2012). It has been argued that clustering 
of mitochondria in the perinuclear region is not unique to autophagy and that this 
clustering might be important for oxidant-rich nuclear domain production, which is 
crucial for hypoxia-induced transcription (Al-Mehdi et al., 2012). Also, some 
conditions that support mitophagy may encourage the movement of mitochondria 
toward lysosomes (Twig and Shirihai, 2011). PGRMC1, which has recently been 
found to promote autophagy (Mir et al., 2013, Mir et al., 2012), was also found in our 
121-OxS set. However, in general in our experiments, it was shown that there was 
limited direct connection to autophagy/mitophagy, with clearer indications for other 
processes.  
 
4.2.4 Mitochondria and the Retrograde Response 
 
Although our experiments were concentrated more on the nucleus, they indirectly 
included mitochondrial processes. Noteworthy, there were 39 proteins out of 121 
significant proteins that were located in the nucleus but also annotated to the 
mitochondria, consistent with extensive retrograde signaling from mitochondria to the 
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nucleus in response to TBP-induced oxidative stress. Mitochondrial retrograde 
signaling to nucleus is a crucial process that is vital within many cellular processes 
and is context-dependent (Kotiadis et al., 2014). The interpretation of the functions of 
these 39 proteins and their roles within our data with oxidative stress was not easy to 
achieve due to the limited knowledge regarding their functions within the nucleus. 
KIAA1967 (also known as deleted-in-breast-cancer-1, DBC1) has recently been 
shown growing interest in the context of cancer mechanisms. Although it is still 
unknown whether KIAA1967 is normally deleted or involved in cancer (Chini et al., 
2013), clear evidence has shown that this protein is located in the nucleus and 
involved in important processes such as the regulation of histone deacetylase 
chromatin remodelling enzymes, transcription factor expression (Joshi et al., 2013) 
and alternative mRNA splicing (Close et al., 2012). It also directly interacts with 
important nuclear receptors such as the α and β oestrogen receptors (Trauernicht et al., 
2007, Koyama et al., 2010). KIAA1967 or DBC1 was also observed within the 
mitochondria (Sundararajan et al., 2005). In our data, changes in KIAA1967 were 
observed, with moderate changes in Sn and St ≈ 1.25, Sc = 0.5, C à N redistribution 
with log2 (Sn/Sc) = 1.3 in response to oxidative stress. Under oxidative stress, it is 
interesting to assume that KIAA1967 might also have crucial mitochondrial functions 
connected to the metabolic changes via the presence of important receptors such as 
oestrogen and other nuclear hormone receptors in the mitochondria (Chen et al., 
2009a).  
On the other hand, it was shown in our data that some proteins have a clear function in 
the mitochondria with no established function in the nucleus. For example, Lon 
protease (LONP1), which is an ATP-dependent protease, was annotated to the 
mitochondrial nucleoid and has well-known functions in the proteolytic clearance of 
damaged proteins (Ngo et al., 2013). LONP1 is also a context-dependent protein; for 
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example, under acute stress, within the mitochondrial matrix, it has been found to play 
a role as a protector protein in the degradation of oxidised proteins, while under 
chronic conditions, Lon level decreases and there is a loss of function (Ngo et al., 
2013). Lon can act as a chaperone (Suzuki et al., 1997) and attaches to the promoter 
sequence in mDNA (Liu et al., 2004) and to transcription factor mitochondrial 
proteins (Matsushima et al., 2010). It has been found to bind to the POLDIP2 protein 
in the mitochondrial nucleoid (Cheng et al., 2005). In our data, Lon was found to show 
considerable nuclear changes with Sc = 1.17, Sn = 0.55, St = 0.67, N à C redistribution 
with log2 (Sn/Sc) = −1.08. These findings suggest that LONP1 might have nuclear 
functions that are modulated and controlled by oxidative stress.  
Many other mitochondrial proteins were detected in the nucleus with interesting 
changes in response to oxidative stress. This might be due to the extensive retrograde 
signaling from the mitochondria to the nucleus, which might include the variable, 
dynamic distribution of proteins between the nucleus and mitochondria. The C. 
elegans ATFS-1 (activating transcription factor associated with stress-1) protein is 
considered a prototype for this type of mitochondrial retrograde control, as it detects 
mitochondrial stress and connects with the nucleus during the mitochondrial unfolded 
protein response. Under normal conditions, ATFS-1 is imported to the mitochondria 
and targeted for degradation. However, under stress conditions, changes in the 
nuclear/mitochondrial distribution are achieved by reduced mitochondrial import 
(Nargund et al., 2012). In this context, several proteins in the 121-OxS set were found 
to be linked with mitochondrial import processes such as HSPA9, PITRM1 and 
PMPCB. This suggested that Nrf2 and Keap1 might have a similar retrograde system 
as it has been previously found that the Nrf2/Keap1 complex is tied to the outer 
mitochondrial membrane via interactions with PGAM5, close to sources of ROS from 
the respiratory chain (Lo and Hannink, 2008).  
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4.3 Haem/Iron Metabolism 
 
From the previous examples above, it is clear that many proteins in our data were 
identified with recognised connections to oxidative stress, mitochondrial pathways and 
the different signaling systems. The information on protein dynamic spatial distribution 
is largely new and for many of these proteins, an explanation of possible nuclear 
functions is now more attractive. Our results suggested that other subcellular organelles 
as well as mitochondria are involved in protein signaling to the nucleus in response to 
oxidative stress and this might include more novel systems that were not previously 
explained. Iron metabolism, for example, was one of the most attractive systems in our 
data. It is already well known to be associated with oxidative stress and connected to 
many diseases such as Alzheimer’s, Parkinson’s and other neurodegenerative diseases 
(Chtourou et al., 2014), as well as type-2 diabetes (Fernandez-Real and Manco, 2013). 
Iron metabolism and iron haemostasis are also intimately connected to cancer, such as 
in colorectal and breast cancer (Marques et al., 2014, Lamy et al., 2014); also, iron 
chelators have been used as therapeutic agents in cancer chemotherapy (Buss et al., 
2004). Iron transport, molecular mechanisms and the subcellular trafficking of proteins 
involved in iron homeostasis have been well established for the important iron systems 
such as the transferrin cycle (Anderson and Vulpe, 2009, Lawen and Lane, 2013). In 
our data, results related to iron systems were indicated as follows: 93 proteins out of 
3569 proteins were annotated to haem/iron with 20 of them being included in the 121-
OxS data set (Supplementary Table 2, external CD). Noteworthy, these proteins were 
annotated to different subcellular locations as follows: 10 proteins were annotated to the 
plasma membrane, 9 to the lysosome, 7 to mitochondria, 5 to the endoplasmic 
reticulum, 4 to endosomes and 1 to Golgi apparatus, with only 4 proteins annotated to 
the nucleus. Cytochrome-b5 type B (CYB5B) and NADH-cytochrome-b5 reductase 3 
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(CYBR3), which are part of the mitochondrial outer membrane, both showed moderate 
increases in abundance as a response to TBP treatment in the cytoplasmic compartment 
(Sc = 1.58 and 1.18, respectively) with the strong redistribution from N à C, showing 
an appreciable decrease in total abundance (St ≈ 0.65), with clearly significantly reduced 
abundance in the nucleus (Sn = 0.43 and 0.61 respectively). Ferritin heavy/light chains 
(FTL and FTH1) as well as haemoxygenase (HMOX1) showed a massive increase in 
total abundance from two- to seven-fold that seem to be mainly equilibrated over the 
two subcellular compartments as a response to the TBP challenge. V-type ATP synthase 
showed an increase in total abundance (St ≈ 1.8) with moderate C à N redistribution 
for many V-type ATP subunits (Figure 3-9). V-type ATP synthase is known to be 
involved in iron homeostasis regulation by providing acidic conditions for iron 
metabolism within lysosomes and endosomes (Diab and Kane, 2013). PGRMC1, which 
is a haem-binding protein with connections to both sterol receptors and autophagy, has 
been found to promote tumorigenesis (Ahmed et al., 2010b). This protein was not 
disconnected by STRING (Figure 3-12, 3-13). The cause of this was suggested to have 
emerged due to a lack of information in the STRING database at the time of analysis, 
even with extensive reports in the literature about the functional roles of these proteins. 
However, this defect did not appear to be because of a drawback in the STRING 
programme, as GeneMania also showed the same results. This means that the currently 
available databases might be dominated by large-scale co-expression and physical 
interaction data sets.  
Many iron- and haem-related proteins also play additional roles that are associated with 
vesicle-mediated subcellular trafficking or are present in the extracellular vesicular 
exosome. The current experiments provided strong evidence for an important role of 
trafficking of iron/haem proteins in the response to oxidative stress. However, the 
interpretation of results was complex, due to the shortage of details about the 
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subcellular trafficking of iron/haem and proteins containing these cofactors in both 
yeast (Cyert and Philpott, 2013) and metazoans (Hamza and Dailey, 2012). This is 
supported by the evidence that	   mitochondria are highly dynamic organelles with 
constitutive processes, including the transfer of proteins by vesicular trafficking to 
organelles such as peroxisomes and lysosomes (Braschi et al., 2010, Mohanty and 
McBride, 2013).  
It has been reported that, under acute oxidative stress, mitochondria are located close to 
the nucleus and fragment in order to initiate the damage control process mitoptosis, 
which is a novel mitochondrial death mechanism, leading to the release of 
mitochondrial proteins into the vesicular exosome (Arnoult et al., 2005, Lyamzaev et 
al., 2008). Some of these proteins have been shown to be altered in nuclear abundance 
in our data. Recent evidence has been found to suggest that mitochondrial cristae 
vesicularise in ageing cells and ATP synthase dissociates into monomers in the inner 
membrane vesicles, which results in reduced cellular function (Daum et al., 2013). One 
of the mitochondrial proteins, LETM1, which was significantly decreased in nuclear 
abundance within the 121-OxS data set (Supplementary Table 2, external CD), is 
known to be involved in crista formation. Reduced expression of the ATP synthase 
subunits has been believed to be essential for the oligomerisation of ATP synthase 
dimers, which may result in fission and the altered organisation of mitochondria 
(Habersetzer et al., 2013). Noteworthy, ATP synthase dimmers, which are different to 
those in mitochondrial cristae, are from the mitochondrial permeability transition pore 
(Bernardi, 2013, Giorgio et al., 2013). Also, TBP has been found to encourage 
mitochondrial depolarisation (Greco and Fiskum, 2010, Greco et al., 2011). This might 
help to explain the changes in many ATP synthase subunits that were observed in our 
data with regard to nuclear abundance, and may offer a clear mechanism for this.  
ROS bursts in mitochondria may play different roles under normal or disease conditions 
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(Xu et al., 2013, Wang et al., 2008b, Wang et al., 2012). Recently, it has been suggested 
that mitochondrial proteins can be transferred by vesicle-mediated transport to 
lysosomes under oxidative stress, which is a different process than mitophagy 
(Soubannier et al., 2012).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   148 
Chapter 5:  Comparison of Changes for Oxidative Stress and 
Cell Cycle Arrest Data 
 
The analyses of the changes in nucleus-cytoplasm subcellular abundance and 
distribution for IMR90 cells subjected either to: (a) siRNA repression of the Cdc7 
kinase, which leads to cell cycle arrest at the G1/S transition via the origin activation 
checkpoint (OAC) for DNA replication (Mulvey et al., 2013); or, (b) mild oxidative 
stress initiated with treatment of the cells with tert-butyl hydrogen peroxide (TBP), have 
been described by (Mulvey et al., 2013, Mulvey et al., 2010) and in previous chapters. 
In each individual study for SILAC ratios for several thousand proteins were obtained, a 
set of about 120 proteins with the most significant changes was identified, and analysis 
with a subcellular spatial razor approach (Mulvey et al., 2013, Pinto et al., 2014) 
revealed that changes both in total protein abundance and in nucleo-cytoplasmic 
distribution resulted in distinctive patterns of protein abundance changes in the 
nuclear/cytoplasmic compartments that are the basis of the cellular response to each 
type of stimulation (Mulvey et al., 2013). In this chapter I present a joint analysis of the 
data from the two experiments to further explore connections between oxidative status 
and the cell cycle. 
The original experiments and MS data collected for Cdc7-depletion-induced cell cycle 
arrest at the origin activation checkpoint for DNA replication (OAC-set (Mulvey et al., 
2013)) and on mild tert-butyl-peroxide-induced oxidative stress (OxS-set (Chapter 3)) 
have been described in detail. These studies included extensive evidence that the cells 
remained viable without perceptible cell death and that the protocols used for 
subcellular fractionation gave highly enriched nuclear fractions with very little or no 
cross contamination with other subcellular components such as mitochondria, 
endoplasmic reticulum, plasma membrane, etc. Flow cytometery analysis indicated cell 
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cycle arrest for both stimulations. In order to compare the changes for oxidative stress 
and cell cycle arrest the original MS data from the two experiments were reprocessed 
under identical conditions against a common UniProt proteome set using MaxQuant 
(Cox and Mann, 2008). For each of the two experiments SILAC ratios were calculated 
for 12 data subsets: each nucleus (N) replicate and the union of the three replicates, each 
cytoplasm (C) replicate and the union of the three replicates, and each (C&N) replicate 
and the union of the three replicates. C&N denotes that the MS data for the nucleus and 
cytoplasm samples was jointly processed to estimate changes in total abundance.  
Correlation of the identified peptides across all biological samples detected 4733 
distinct proteins. With a limit of at least two sequenced peptides and at least one sample 
with a minimum of three SILAC ratio counts, 4048 proteins were quantified 
(Supplementary Table 4, external CD).  
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Table 5-1. Summary of Significance B Selection Significant Proteins in Both OAC and 
OxS data sets1 (Supplementary Table 5, external CD). 
 
 
 
 
 
 
 
 
 
STRINGENT STRICT MODERATE RELAXED MINIMUM
union 6 0.0025 0.0075 0.015 0.02 0.05
replicates
Sn 3 0.0075 0.015 0.03 0.05 0.07
Sc 3 0.0075 0.015 0.03 0.05 0.07
StD(C&N) 3 0.0075 0.015 0.03 0.05 0.07
union 6 0.9 0.8 0.6 0.5 0.4
replicate 3 0.8 0.6 0.5 0.4 0.3
STRINGENT STRICT MODERATE RELAXED MINIMUM
112 145 196 229 308
98 125 156 195 263
224 289 382 467 633
14 19 30 43 62
Summary'of'Significance'B'Selection'Criteria'for'Signficant'Proteins1
B.'NUMBER'OF'SIGNIFICANT'PROTEINS
1DProteinsDacceptedDasDsignificantDforDchangesDinDabundanceDand/orDdistributionDsatisfyDtheD
limitsDforDtheDunionDandDforDatDleastDtwoDreplicatesD.
dataDset
OXSDonly
OACDonly
TOTAL
BOTH
A.'SELECTION'LIMITS
SigBDlimitD<=SILACDratioDcountsDD>=
abundance
distribution |Dlog2(Sn/Sc)D|D>=
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Because the absolute magnitude of the changes in protein abundance are dependent on 
the degree of Cdc7 kinase suppression (OAC) or on the concentration of tert-butyl 
peroxide to which the cells are exposed (OxS), it is not very helpful to directly compare 
the absolute changes in protein abundance between the two experiments. Instead, we 
used a procedure that identifies sets of proteins with the most significant changes in 
abundance relative to all quantified proteins in each individual experiment. MaxQuant 
uses a procedure that takes into account the recorded MS intensity for each protein to 
calculate an outlier probability (Significance B score, hereafter SigB) that identifies the 
most significantly changed proteins in each data set (Cox and Mann, 2008). Table 5-1 
shows the number of significant proteins for different cutoffs of SigBunion, SigBreplicate 
and the distribution parameter log2(Sn/Sc), which detects changes in subcellular 
distribution even in the absence of changes in total abundance. In constructing the sets 
of proteins in Table 5-1 we restricted the proteins accepted as significant to those with 
appreciable recorded MS intensity and substantial numbers of SILAC ratio counts by 
using a SigBunion limit for the union of the three replicates, a SigBreplicate limit to ensure 
reproducibility over the replicates, as well as a minimum number of SILAC ratio 
counts. At all cutoff limits, roughly equal numbers of proteins were identified as 
significant in the OxS and OAC data sets, i.e. the response to the two different cellular 
stimulations is sampled approximately equally. As an initial test for possible 
similarities/differences between response to oxidative stress and cell cycle arrest, we 
compared the OxS and OAC sets of proteins using the stringent selection criteria 
(Supplementary Table 5, external CD). For the 224 proteins selected as most significant 
there were 112 proteins significant only for OxS, 98 proteins significant only for OAC 
and 14 proteins that were significant for both cellular stimulations.  
For 110 proteins, Sc and Sn were quantified in both experiments. Their behavior in the 
two experiments is shown in a 3D spatial razor plot (Figure 5-1A). In this type of plot, 
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changes in subcellular nucleo-cytoplasmic distribution are displayed in a (Sn/St, Sc/St) 
distribution plane that is independent of changes in total abundance while changes in 
total abundance are displayed on an orthogonal St axis that is color-coded according to 
the scale at the right (Figure 5-1). Conservation of mass restricts the data points to two 
quadrants of the distribution plane corresponding to N à C or N ß C redistribution 
(Mulvey et al., 2013, Pinto et al., 2014). Out of these 110 proteins, 45 showed greater 
than 1.5-fold changes in total abundance (St) and 62 showed |log2(Sn/Sc)| > 0.9 in one or 
both of the OxS and OAC data sets. That is, changes both in total abundance and in 
nuclear-cytoplasmic distribution are prominent in the cellular responses. We have 
previously shown that changes in total abundance (St) and in subcellular distribution 
(Sn/Sc) are not correlated for either OxS or OAC (Mulvey et al., 2013), i.e., the changes 
in compartmental abundance (Sn and/or Sc) do not simply mirror changes in total 
abundance.  
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Figure 5-1. 3D Spatial Razor Plots Comparing  Response to OxS and OAC. Quadrants corresponding to N ! 
C and N " C redistribution are shown in the distribution plane and changes in total abundance are colour coded 
according to the scale at the right.  (A) 110 proteins that were significant in both the OxS and OAC data sets with 
stringent selection criteria. (B) 12 proteins that were most significant in both the OxS and OAC data sets. (C) 14 
proteins with GO annotation to DNA replication and/or cell cycle. 
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Of the 14 proteins common to the OxS and OAC stringent sets, both Sc and Sn were 
quantified in both experiments for 12 proteins (Figure 5-1B). Although over the 
different proteins the changes in abundance and distribution tend to vary continuously 
and hence the classes are not completely separable, comparison of OxS and OAC 
distinguishes four approximate types of response behavior. (a) Proteins for which 
changes show the same trend for OxS and OAC. For example FTL, FTH1 and TGFBI 
show large increase in total abundance with little redistribution in both experiments, 
KPNA2 shows decreased total abundance with limited redistribution in both 
experiments, while PYCR1 shows decreased total abundance and N à C redistribution 
in both experiments. (b) Proteins for which total abundance changes show the same 
trend, but distribution changes tend to be different (SET, CNN1, HMOX1). (c) Proteins 
for which total abundance changes are different, but redistribution shows the same trend 
(PCNA, HADHA, COL1A1), (d) Proteins for which both total abundance and 
distribution show opposing trends (HSPA9). Such differences suggest that there may be 
some protein networks with similar behavior for OxS and OAC, other networks that are 
characteristic of one or the other of OxS or OAC, and some networks that behave 
differently between the two cellular responses. Further evidence for differential 
behavior was obtained from the 12 proteins that were quantified in both the nucleus and 
cytoplasm and were annotated by GO to DNA replication and/or cell cycle, which were 
the dominant biological processes determined for OAC (Mulvey et al., 2013). As shown 
in Figure 5-1C, changes for subunits of the MCM helicase complex (MCM3, MCM5), 
which is essential for pre-Replication Complex loading at DNA replication origins and 
is a direct substrate of Cdc7 kinase, are limited to OAC. Conversely, changes in several 
proteasome subunits (PSMC5, PSMD5, PSMD6, PSMD11), Ubiquitin-40S (RPS27A) 
and Septin 2 (SEPT2) are limited to OxS. The proteins PCNA, FEN1, PSME3, KPNA2, 
ACAT1 and GNB2L1 show indications of participating in response to both OxS and 
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OAC. In general the results in Figure 5-1 indicate that changes in both total abundance 
and in subcellular distribution are important to determining the compartmental 
abundance of proteins and hence in determining cellular response. Furthermore, at all 
levels of stringency in the selection criteria for significant proteins (Table 5-1), a small 
proportion of the significant proteins (6-9%) is common to both OxS and OAC. 
Although these initial analyses are helpful in understanding and visualizing trends, 
individual determination of the sets of most significant OxS and OAC proteins restricts 
the number of proteins that can be compared, limits ability to identify network 
responses that are similar, different or exclusive to one or the other of OxS and OAC, 
and limits identification of possible connections between the networks. We therefore 
carried out a direct, joint analysis of the full OxS and OAC data sets.  
 
5.1 Joint Spatial Razor Plots for OxS and OAC 
 
At the level of at least three SILAC ratio counts in the union, there were a total of 6099 
pairwise values of one or more of Sc, Sn, St and Sn/Sc for the same protein in both the 
OAC and OxS data sets. These corresponded to 2388 different proteins. To jointly 
analyze the data sets for similarities and differences in cellular response, to include 
proteins which were quantified in only one of the subcellular compartments and to 
handle all four types of comparisons (Sc, Sn, St, Sn/Sc) equivalently, we plotted SOXS / 
SOAC versus SOXS • SOAC for each of the four types of SILAC ratios. In this “joint spatial 
razor” plot the 6099 data points cluster around the origin, that is, only a minority of 
proteins show major changes in their SILAC ratios in either experiment (Figure 5-
2A,B). The radial distance from the origin for the data points gave highly similar 
distributions for each of the four types of comparison, as shown for Sn and the union 
over (Sc, Sn, St, Sn/Sc) in Figure 5-2C.   
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The “joint spatial razor” plot classifies the SILAC ratios into regions such that the 
cellular response can be analyzed for dominance of one stimulation, for similarity in 
both responses or for opposite response to the two stimulations (see the colored radial 
regions in Figure 5-2D). This is very helpful for visualizing the nature of any 
correlation in the changes for OxS and OAC. For example, the heavy subunit of ferritin 
(FTH1) shows a strong increase in total abundance for both OxS and OAC, but little or 
no subcellular redistribution, so that abundance in both the nuclear and cytoplasmic 
compartments is strongly increased for both OxS and OAC. Conversely, proliferating 
cell nuclear antigen (PCNA) shows strong N à C redistribution, but limited change in 
total abundance for both OxS and OAC, so that nuclear abundance is substantially 
decreased for both OxS and OAC. OAC is strongly dominant for DNA replication 
licensing factor MCM5. The combination of reduced total abundance and strong N à C 
redistribution leads to a major reduction in nuclear abundance coupled to an appreciable 
increase in cytoplasmic abundance. Pyrroline-5-carboxylate reductase 1 (PYCR1) 
shows strong N à C redistribution for both OxS and OAC, but reduction in total 
abundance predominantly for OxS. 
This results in strong reduction in nuclear abundance mainly for OxS and strong 
increase in cytoplasmic abundance mainly for OAC. In short, the combination of 
changes in total abundance and in subcellular distribution can lead to complex patterns 
of changes in the compartmental abundances that vary between OxS and OAC.  
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Figure 5-2. Joint Spatial Razor Plot of the OxS and OAC data sets. (A) Plots of log2(SOXS/SOAC) vs log2(SOXS 
•SOAC) for Sn/Sc, St, Sc, Sn, (back to front). The four types of comparisons are color coded according to the legend at 
the top. (B) Expansion of the central region of (A) with reverse back to front order. (C) Radial distribution of the 
data points in (A) for the union over all 6090 data points and for the 1703 nuclear data points. (D) Examples of 
response for four selected proteins (see text). The dashed black circles in (B) and (D) correspond to radius = 1.1 as 
indicated in (C). The colored radial slices (see D) represent angular regions where the dominant response is at least 
twice that of the neighboring regions. The circled + and – symbols denote increases/decreases in abundance (Sn, Sc, 
St) or C → N / N → C redistribution (Sn/Sc) respectively. Figure was designed by JGZ for publication in 
preparation by Radulovic et all, 2015. 
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By selecting proteins that correspond to specific functional processes, e.g. glycolysis 
(Figure 5-3A), or to specific subcellular locations, e.g. mitochondria (Figure 5-3B), the 
functional interplay between changes in abundance and in subcellular location can begin 
to be visualized. For example, 8 proteins of the glycolysis/gluconeogenesis enzymatic 
cascade were monitored in both the cytoplasm and nucleus in both experiments. Only 
hexokinase 1 (HK1) showed appreciable change: N ß C redistribution without change 
in total abundance led to strongly increased nuclear abundance only for OxS (Figure 5-
3A). This is a known effect that is related to the metabolic fate of glucose and to 
metabolism in cancer cells (Mathupala et al., 1997, Neary and Pastorino, 2010, Wilson, 
2003, John et al., 2011).  
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Figure 5-3. Joint Spatial Razor Plots for Selected Proteins. A. Eight proteins of the glycolytic 
enzymatic cascade (HK1, GAPDH, TPI1, ALDOA, ENO1, PKM2, PGAM1, LDHA). B. Five proteins 
with GO annotation to mitochondria.  
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None of the other seven enzymes (GAPDH, TPI1, ALDOA, ENO1, PKM2, PGAM1, 
LDHA) showed major changes in either experiment.  
Similarly, Figure 5-3B shows the joint analysis for 5 proteins with GO annotations of 
mitochondrion. Mitochondrial fission 1 protein (FIS1) and Enoyl-CoA delta isomerase 
2 (ECI2) show similar, predominant response for OxS involving decreased total 
abundance and N à C redistribution, hence strong decreases in nuclear abundance with 
little change in cytoplasmic abundance. Subunit alpha of the electron transfer 
flavoprotein (ETFA) shows little change in total abundance and opposite N ßà C 
redistribution for OxS and OAC, hence moderate, opposed changes in nuclear 
abundance. Subunit alpha of isocitrate dehydrogenase [NAD] (IDH3A) shows small 
decreases in total abundance for OxS and OAC and largely opposite N ßà C 
redistribution, which results in a modest increase in nuclear abundance for OxS and an 
appreciable increase in cytoplasmic abundance for OAC.  
 Finally, mitochondrial import inner membrane translocase subunit TIM44 shows 
increased total abundance only for OAC and strong, opposite N ßà C redistribution, 
which results in a substantial increase in abundance in the cytoplasmic compartment for 
OAC (Sc = 2.04, Sn = 0.83) and in the nuclear compartment for OxS (Sc = 1.04, Sn = 
1.68). These and other changes are considered further in the context of a joint network 
analysis (in preparation by Radulovic et all, 2015). Overall these results suggested that 
nucleo-cytoplasmic trafficking of proteins is an integral component of the cellular 
response to both stimulations and provided an additional evidence for the possible 
involvement of nuclear import/export processes and/or of vesicle-mediated transport 
processes.  
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Chapter 6: Conclusions and Impact of these Findings 
 
Major conclusion of the thesis can be summarised as follows: 
 
Different conditions can affect protein behaviours and distributions over the subcellular 
compartments, as in mild oxidative stress, which also activates cell cycle checkpoints 
within the IMR90 fibroblasts, leading to cell cycle arrest.  
The results of the thesis clearly show the involvement of numerous proteins with 
various functions, including cell cycle control, mitochondrial function, iron metabolism, 
signaling systems and other functional processes, with significant changes in nucleo-
cytoplasmic compartmental abundance in response to oxidative stress.  
These changes also included proteins that are known to be present in different non-
nuclear subcellular locations.  
Protein redistribution between the nucleus and cytoplasm is equally as important as 
changes in total protein abundance in order to achieve the appropriate changes in 
compartmental abundance; this is because changes in total protein abundance alone still 
give a general overview without a comprehensive picture for the appropriate changes 
the cellular response to TBP. 
The cellular behaviours and characteristics have been observed before under different 
conditions, including cell cycle arrest (Mulvey et al., 2013) at the original activation 
checkpoint for DNA replication and in response to hypoxia (Henke et al., 2011). 
Nucleocyoplasmic trafficking of proteins has also been observed in breast cancer in 
response to oestrogen stimulation (Pinto et al., 2014), which supports the concept of the 
need to learn more about the mechanism of protein distribution and their behaviours in 
different subcellular locations, such as the nucleus.  
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A total of 115 proteins in 121-OxS were found in the nucleus, with 45 also annotated by 
GO to the nucleus. However, the nuclear function of 80 proteins was unclear. There 
were sixty-three proteins found in our data with highly significant changes in Sn; 
however, 40 proteins were found not to be annotated to the nucleus. These proteins are 
linked to many functional processes and suggest many interesting entry points in the 
context of oxidative stress.  
The involvement of iron/haem proteins in response to oxidative stress is not surprising, 
as haem has been shown to be crucial for eukaryotic evolution (Chiabrando et al., 
2014).  
Moreover, the specific selection of RAB proteins and kinesins that are known to be 
intimately involved in vesicular trafficking (Huotari and Helenius, 2011) (RAB2A, 
RAB5A, RAB5B, KIF14, KIF20A) gave a strong indication of the contribution of 
vesicular trafficking in the nucleus in response to TBP treatment.  
Apart from cancer cells, around 2-5% of the total of cellular proteins showed significant 
changes under specific conditions. 
These results clearly show very selective changes in the local abundance over the 
different subcellular locations, which can help to improve the model for cellular 
function. This can be achieved by the inclusion of spatial location as an explicit factor 
coupled with powerful databases to further understand the cellular interactions.  
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Chapter 7: Future Studies  
	  
Spatial razor proteomics coupled with downstream bioinformatics analysis are a potent 
way to study protein abundance and behaviour under specific conditions. As mentioned 
before, our present experiments coupled with suggestive evidence from the literature 
can enable an interpretation of this data, which would seem to be that vesicular 
trafficking occurs more widely in higher eukaryotic cells than is presently known. The 
supporting evidence for that is that GO annotated around 1427 proteins in our data to 
“vesicle-mediated transport” or to “cytoplasmic vesicle”. This also suggests that the 
nucleus, mitochondria, other subcellular organelles and haem/iron proteins participate in 
vesicular trafficking. Therefore, the involvement of iron/haem proteins in trafficking led 
us to suggest three possibilities for further investigation of the possible role of proteins 
involved in iron/haem metabolism in subcellular trafficking in response to oxidative 
stress. First, subcellular trafficking of the membrane-associated progesterone receptor 
(MAPR) family PGRMC1, PGRMC2, neudesin and neuferricin of cytochrome-b-
related, haem-containing proteins (Kimura et al., 2012) could be investigated. The 
prototype of this family is PGRMC1, which showed strong N à C redistribution with 
log2 (Sn/Sc) = −1.17 in our data with no change in total abundance (St = 0.99), resulting 
in a strong decrease in nuclear abundance (Sn = 0.54) and a moderate increase in 
cytoplasmic abundance (Sc = 1.22). PGRMC1 has been widely reported as part of a 
plasma membrane receptor for progesterone that acts independently of the classical 
progesterone nuclear hormone receptor in most cells, including in neuronal cells (Bali et 
al., 2013, Petersen et al., 2013).  
PGRMC1 has recently been suggested as an attractive target for future investigations 
for several reasons: it was found to be part of a protein complex that has the binding site 
for the enigmatic sigma-2-recptor, which is known to regulate lipid metabolism, 
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hormone signaling, and it is certified as a biomarker for tumour cell proliferation, with 
both the receptor and PGRMC1 being important for cancer (Xu et al., 2011). According 
to previously published reports, PGRMC1 is located within several cellular 
compartments such as the ER and mitochondria (Xu et al., 2011), the cellular vesicular 
fraction (Ahmed et al., 2010a), in the perinuclear region and in the nucleus (Bali et al., 
2013). PGRMC1 has been found to play a role in autophagy (Mir et al., 2013), 
regulating genes that inhibit apoptosis via progesterone (Peluso et al., 2010, Peluso et 
al., 2012) and can also act as an adaptor protein for membrane receptors (Thomas et al., 
2014). PGRMC1 has been found to interact with plasminogen activator inhibitor 1 
RNA-binding protein (PAIRBP1) for nuclear transcriptional functions (Peluso et al., 
2013) and co-localises with aurora kinase b (AURKB) in chromatin during oocyte 
maturation processes (Luciano et al., 2010). AURKB and plasminogen activator 
inhibitor 1 (SERPINE1) were found in our significant 121-OxS data set. This suggests 
intimate connections between oxidative stress and various PGRMC1 functions, and 
PGRMC1 may have redox ability that could be crucial for its multitude of functions. As 
a haem-containing protein with multiple known subcellular locations, interactions, and 
functions, PGRMC1 seems to be an excellent candidate for the further elucidation of 
possible connections between haem protein trafficking and oxidative stress. 
Cytochrome b5 type B (CYB5B) and its partner NADH-cytochrome b5 reductase 3 
(CYB5R3) were also found in our data, which are mitochondrial outer membrane 
proteins; these showed noticeable N à C redistribution, and may also be useful 
candidates for further investigation.  
The second target for further investigation and future work is the subcellular trafficking 
of NADPH oxidase 4 (NOX 4). NOX4 is an integral membrane protein that consists of 
six transmembrane helices that contain two haem groups (Bedard and Krause, 2007). 
Under specific conditions that apparently include H2O2, NOX4 and POLDIP2 
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dynamically co-localise to the nucleus for the production of collagen (Lyle et al., 2009). 
In our data, NOX4 was not quantified; however,	  there was an increase in the nuclear 
POLDIP2 and a reduction in cellular collagen (COL1A1) that may be mediated via the 
proline regulatory axis (Figure 3-14C). NOX4 has been detected in different subcellular 
locations, including the	  endoplasmic reticulum (Van Buul et al., 2005), mitochondria 
(Ago et al., 2010, Block et al., 2009) and particular plasma membrane subcellular 
domains such as focal adhesions (Hilenski et al., 2004) and invadopodia (Diaz et al., 
2009, Diaz and Courtneidge, 2012). NOX4 can produce ROS in the nucleus 
(Matsushima et al., 2010, Spencer et al., 2011), mitochondria (Kartha et al., 2008, Ago 
et al., 2010) and ER (Sciarretta et al., 2013) and it has been found to be associated with 
different cellular functions and diseases such as cancer, diabetic kidney disease, 
cardiovascular disease, Alzheimer’s disease, fibrosis, and atherosclerosis (For review, 
see (Barnes and Gorin, 2011, Drummond et al., 2011, Block and Gorin, 2012, Bedard 
and Krause, 2007)). As mentioned before, the structure and catalytic function of NOX4 
allow it to transfer electrons from NADPH across the cellular membrane to molecular 
oxygen locations (Bedard and Krause, 2007). However, the mechanism responsible for 
NOX4 transport to different subcellular locations is still unclear due to limited 
information. Thus, vesicular trafficking might help to understand how for an integral 
membrane protein such NOX4 with unknown function to import/export via nuclear pore 
reaches the nucleus.  
The third interesting suggestion involves the possibility of vesicle trafficking in iron 
homeostasis via studying the subcellular trafficking of the V-type ATPases (ATP6). V-
type ATPases regulate the cellular pH of the cytoplasm and acidic organelles 
(Beyenbach and Wieczorek, 2006, Diab and Kane, 2013) to protect cells against the loss 
of pH homeostasis due to oxidative stress and iron misregulation (Milgrom et al., 2007). 
This might be an attractive target for studying the functional roles of V-type ATPases. 
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Iron interacts with hydrogen peroxide causing cellular damage; for that reason, V-type 
ATPases mitigate and prevent this effect by stabilising the acidic environment within 
the endosomes and lysosomes (Valko et al., 2005).  
P26/SQSMT1 interacts with V-type ATPase in the lysosomes and activates the 
rapamycin mTOR pathway, which is involved in important cellular functions such as 
cell growth and autophagy (Duran et al., 2011), senescence and amino acid metabolism 
(Zoncu et al., 2011). The insulin receptor-signaling pathway is also affected by V-type 
ATPases; for example, it has been found that the acidic environment in the endosomes 
leads insulin to dissociate from its receptor via V-type ATPases (O'Callaghan et al., 
2010). This pathway was also observed in our data (Table 3-2). However, there were 21 
proteins known to be involved in the insulin receptor pathway that were not significant 
in our data in either total or compartmental abundance. This might reflect the fact that 
there was a consequence of changes, which might occur as a response to the processes 
acidification/depolarisation of endosomes/lysosomes. As a result, the depolarisation of 
endosomes and lysosomes due to cyclic bursts of pH (Valko et al., 2005, Diab and 
Kane, 2013) might explain normal physiological mechanisms for discarding V-type 
ATPases. Most V-type ATPase subunits are currently annotated by GO to most of the 
cellular compartments, such as the mitochondria, plasma membrane, endosomes, 
lysosomes, Golgi apparatus, vacuoles, nucleus, and cytoplasmic vesicles. Noteworthy, 
V-type ATPases have also been found to be involved in vesicle trafficking (Beyenbach 
and Wieczorek, 2006, Brown et al., 2009, Gu and Gruenberg, 2000). One of these 
subunits is ATP6V0C, which has been found to regulate the metabolism of autophagy 
proteins that are accumulated in age-related neurodegenerative diseases (Mangieri et al., 
2014). Moreover, the renin receptor ATP6AP2 was found in our data with St = 1.59, Sn 
= 1.71. ATP6AP2 is also known to interact with V-type ATPases in the Wnt/β-catenin 
signaling pathway, but there are still unclear connections to the renin−angiotensin 
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hormonal system, similar to various other signaling systems (Kops et al., 2002b). 
Interestingly, subunits of V-type ATPases might be involved in a variety of 
processes/locations different to those that have been well studied, such as the transfer of 
these subunits to the nucleus under conditions of oxidative stress. 
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